12.07.2015 Views

2009 - 2010 - University at Buffalo School of Pharmacy and ...

2009 - 2010 - University at Buffalo School of Pharmacy and ...

2009 - 2010 - University at Buffalo School of Pharmacy and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Message from the DeanSolid Found<strong>at</strong>ion Prepares Strong FutureAs I look back on our accomplishments during the <strong>2009</strong>-<strong>2010</strong> academic year, I am reminded <strong>of</strong> one <strong>of</strong> our gre<strong>at</strong>est accomplishmentsto d<strong>at</strong>e – the Groundbreaking Ceremony for John <strong>and</strong> Editha Kapoor Hall. This event represents the beginning <strong>of</strong> our future aswell as the focus <strong>of</strong> all we currently strive to achieve <strong>and</strong> enhance. Kapoor Hall will allow us to <strong>at</strong>tain our curricular objectives,advance our research, exp<strong>and</strong> collegial interactions <strong>and</strong> assist all members <strong>of</strong> the school in reaching their goals. The September<strong>2009</strong> Groundbreaking Ceremony laid the found<strong>at</strong>ion for our occupancy <strong>of</strong> the building in the Summer <strong>of</strong> 2012.Our PharmD students were very active in pharmacy <strong>and</strong> healthcare policy objectives. Legisl<strong>at</strong>ively, SPAWNY organized a verysuccessful <strong>Pharmacy</strong> Legisl<strong>at</strong>ive Advocacy Day where local legisl<strong>at</strong>ors visited the school <strong>and</strong> spoke with students about st<strong>at</strong>ehealth care policy <strong>and</strong> budget. APhA-ASP tackled legisl<strong>at</strong>ive issues with the cre<strong>at</strong>ion <strong>of</strong> a video showing how pharmacy impactshe<strong>at</strong>h care reform <strong>at</strong> the local <strong>and</strong> regional levels. This was submitted to APhA as well as st<strong>at</strong>e <strong>and</strong> federal congressional<strong>of</strong>fices. N<strong>at</strong>ionally, the UB Team again took top honors with fourth place recognition <strong>at</strong> the AACP’s Pruitt-Schutte Business PlanCompetition. On campus, our students represented the school well by their invited particip<strong>at</strong>ion <strong>at</strong> the UB Celebr<strong>at</strong>ion <strong>of</strong> AcademicExcellence where PharmD <strong>and</strong> pharmaceutical sciences students showcased their research work via poster present<strong>at</strong>ions.The continued high caliber work <strong>of</strong> our faculty continues to be recognized. Dan Brazeau received the UB <strong>2010</strong> Teaching Award,Jerry Schentag received the UB <strong>2010</strong> Faculty Entrepreneur Award <strong>and</strong> Brian Tsuji was the recipient <strong>of</strong> the Pfizer <strong>2009</strong> ASPIREYoung Investig<strong>at</strong>or Award in Antibacterial Research. The faculty <strong>at</strong> large has accomplished a gre<strong>at</strong> deal in all areas <strong>of</strong> scholarship<strong>and</strong> has their efforts continue to be recognized here <strong>at</strong> the school as well as by their n<strong>at</strong>ional peers.Their dedic<strong>at</strong>ion <strong>and</strong> intellectual rigor continually reinforce our high st<strong>and</strong>ards <strong>of</strong> excellence.The <strong>2009</strong>-10 accomplishments <strong>and</strong> recognitions noted throughout thisannual report gave a strong found<strong>at</strong>ion to our current activities. As wereview budget <strong>and</strong> curricular objectives in prepar<strong>at</strong>ion for our upcomingaccredit<strong>at</strong>ion <strong>and</strong> move to Kapoor Hall, it is evident how our paststrengths have prepared us to meet these important future events.Warm regards,Wayne K. AndersonPr<strong>of</strong>essor <strong>and</strong> Dean2


O U R M I S S I O N S TA T E M E N TThe mission <strong>of</strong> the <strong>University</strong> <strong>at</strong> <strong>Buffalo</strong> <strong>School</strong> <strong>of</strong> <strong>Pharmacy</strong> is to educ<strong>at</strong>estudents in pharmacy practice <strong>and</strong> the pharmaceutical sciences,to cre<strong>at</strong>e <strong>and</strong> dissemin<strong>at</strong>e knowledge in pharmacy practice <strong>and</strong> thepharmaceutical sciences, to provide p<strong>at</strong>ient care, <strong>and</strong> to provide servicesto the community <strong>at</strong> large based upon this knowledge. This mission isto be achieved consistent with the highest ethical st<strong>and</strong>ards <strong>and</strong> withrespect for diversity <strong>and</strong> cultural sensitivity.The mission recognizes pharmaceutical care as a mode <strong>of</strong> pharmacypractice within the health care team in which the p<strong>at</strong>ient is empowered“to achieve the desired outcomes <strong>of</strong> drug <strong>and</strong> rel<strong>at</strong>ed therapy.”Table <strong>of</strong> ContentsBENCH TO BEDSIDE, BEDSIDE TO BENCH 2EDUCATION 6The mission also recognizes th<strong>at</strong> research in the broad area <strong>of</strong> theclinical sciences, pharmaceutical sciences <strong>and</strong> educ<strong>at</strong>ion is necessaryto cre<strong>at</strong>e <strong>and</strong> maintain a body <strong>of</strong> knowledge needed for pr<strong>of</strong>essionaleduc<strong>at</strong>ion, health care delivery <strong>and</strong> the advancement <strong>of</strong> science. In thiscontext, our goal is to enhance the local, n<strong>at</strong>ional <strong>and</strong> intern<strong>at</strong>ionalleadership <strong>of</strong> the <strong>School</strong> <strong>of</strong> <strong>Pharmacy</strong> <strong>and</strong> continue it as one <strong>of</strong> thestrong components <strong>of</strong> the <strong>University</strong> <strong>at</strong> <strong>Buffalo</strong> <strong>and</strong> the St<strong>at</strong>e <strong>University</strong>RESEARCH AND TRAINING 12SCHOLARSHIP 16THANKS TO YOU 26ALUMNI RELATIONS 35FINANCIAL REPORTS 36<strong>of</strong> New York system. This will involve a focus on those areas <strong>of</strong> uniquestrength within the school <strong>and</strong> those areas th<strong>at</strong> form unique, interdisciplinarybridges within the university.1


On the bench, Associ<strong>at</strong>e Pr<strong>of</strong>essorJavier G. Blanco, PhD has a keenresearch eye fixed on genotyping as away to reduce the risk <strong>of</strong> congestiveheart failure among childhood cancersurvivors.Bench to Bedside,Bedside to BenchConsidering more efficient clinical management <strong>of</strong> diabetes <strong>and</strong> safer regimens for curing cancerDefining more efficient clinical management <strong>of</strong> diabetes <strong>and</strong> safer drug regimensfor curing cancer are critical pursuits among today’s medical practitioners.Rising to this challenge, two UB SoPPS faculty are leading notable researchth<strong>at</strong> points to gre<strong>at</strong>er personaliz<strong>at</strong>ion <strong>of</strong> cancer <strong>and</strong> diabetes pharmacotherapyfor the best overall outcomes for p<strong>at</strong>ients <strong>and</strong> providers.At bedside, Clinical Assistant Pr<strong>of</strong>essor Erin Slazak, PharmD has completeda pilot clinical study th<strong>at</strong> articul<strong>at</strong>es best practice for cost- <strong>and</strong> care-effectivelong term management <strong>of</strong> Type 2 diabetes.On the bench, Associ<strong>at</strong>e Pr<strong>of</strong>essor Javier G. Blanco, PhD has a keen researcheye fixed on genotyping as a way to reduce the risk <strong>of</strong> congestive heart failureamong childhood cancer survivors.2


Bench to Bedside, Bedside to BenchConsidering more efficient clinical management <strong>of</strong> diabetes <strong>and</strong> safer regimens for curing cancerpharmaceuticals, but only a fraction<strong>of</strong> p<strong>at</strong>ients develop a toxic event,”Blanco explains, adding th<strong>at</strong> thenumbers are high enough to warrantcaus<strong>at</strong>ion research. “We thought,maybe there are some genetic factorsth<strong>at</strong> make these p<strong>at</strong>ients more proneto these kinds <strong>of</strong> toxicities. Wh<strong>at</strong> ifwe can pinpoint those genetic factorsin advance, before administeringany therapy? Th<strong>at</strong>’s the whole idea.Maybe there are genetic factors th<strong>at</strong>predispose people to these toxicities.”In collabor<strong>at</strong>ion with the Children’sOncology Group, <strong>of</strong> which he is amember – <strong>and</strong> working closely withSmita Bh<strong>at</strong>ia, MD, MPH, Chair <strong>of</strong> theDepartment <strong>of</strong> Popul<strong>at</strong>ion Sciences <strong>at</strong>City <strong>of</strong> Hope N<strong>at</strong>ional Medical Centerin Duarte, California – Blanco mounteda pilot study to test this hypothesis.The study, which began seven yearsago, compared DNA genotypes <strong>of</strong>childhood cancer survivors diagnosedwith heart disease to a control group<strong>of</strong> cancer survivors without heart disease. About 80 percent<strong>of</strong> the participants began tre<strong>at</strong>ment after 1981; the medianage <strong>of</strong> diagnosis was 7.5 years, <strong>and</strong> median advent <strong>of</strong> cardiomyop<strong>at</strong>hywas 7.1 years.“The idea is th<strong>at</strong> small genetic differences between cases<strong>and</strong> control dict<strong>at</strong>e this risk. But there are chances <strong>of</strong> findingdifferences everywhere, because the human genome is veryplastic,” Blanco says. “So we put together a list <strong>of</strong> c<strong>and</strong>id<strong>at</strong>epolymorphisms. We narrowed it down to a list <strong>of</strong> genes th<strong>at</strong>we believe are involved in the genesis <strong>of</strong> this anthracyclinerel<strong>at</strong>edcardio toxicity.”Using this c<strong>and</strong>id<strong>at</strong>e gene approach, Blanco <strong>and</strong> his researchteam were able to isol<strong>at</strong>e a tiny gene variant rel<strong>at</strong>ed to cardiotoxic risk. “Th<strong>at</strong> was really exciting. Everybody was happy.We ended up publishing a study,” he laughs.“We repe<strong>at</strong>ed the same analysis with a different <strong>and</strong> muchlarger set <strong>of</strong> 165 cases with cardiomyop<strong>at</strong>hy <strong>and</strong> 323 survivorswithout heart disease,” he continues, adding th<strong>at</strong> thesecond analysis utilized detailed tests to diagnose cardiacdisease. Further pharmacogenetic analysis showed a cleardose-response rel<strong>at</strong>ionship between anthracycline use <strong>and</strong>cardiomyop<strong>at</strong>hy among p<strong>at</strong>ients with certain CBR enzymerel<strong>at</strong>edgenotypes.“We were able to valid<strong>at</strong>e our findings. And th<strong>at</strong>’s wh<strong>at</strong> wepresented <strong>at</strong> the ASCO conference last year, the valid<strong>at</strong>ion in <strong>at</strong>otally independent cohort <strong>of</strong> cancer survivors.”Clinical Assistant Pr<strong>of</strong>essor Erin Slazak also is engaged in asecond round <strong>of</strong> research to valid<strong>at</strong>e the initial findings <strong>of</strong>her clinical pharmacy services (CPS) study, which supports thepositive impact th<strong>at</strong> pharmacists can have in enhancing p<strong>at</strong>ientcare while decreasing health care costs.Slazak is a <strong>Buffalo</strong> n<strong>at</strong>ive who earned her PharmD in 2004,followed with a UB pharmacy practice residency in ambul<strong>at</strong>orycare – <strong>and</strong> is now a well-respected educ<strong>at</strong>or <strong>and</strong> innov<strong>at</strong>iveacademician in the field <strong>of</strong> diabetes. Her clinical research isfocused on p<strong>at</strong>ient-centered pharmacotherapy management<strong>of</strong> ambul<strong>at</strong>ory disease st<strong>at</strong>es <strong>and</strong> the effect <strong>of</strong> pharmacistintervention on health care <strong>and</strong> economic outcomes.Her current CPS research is mounted through MedSense, apharmacist-led, p<strong>at</strong>ient centered pharmacotherapy programdeveloped by UB SoPPS <strong>and</strong> Lifetime Health Medical Group,the regional primary care physician group where Slazak seesp<strong>at</strong>ients <strong>and</strong> oversees student <strong>and</strong> resident educ<strong>at</strong>ion. Sheis also the program coordin<strong>at</strong>or <strong>of</strong> the MedSense ProgramResearch Initi<strong>at</strong>ive, an interdisciplinary approach to care forp<strong>at</strong>ients with complex disease st<strong>at</strong>e <strong>and</strong> medic<strong>at</strong>ion burdens,particularly those with uncontrolled Type 2 diabetes or themetabolic syndrome.“Our program allows us to educ<strong>at</strong>e p<strong>at</strong>ients on the management<strong>of</strong> chronic disease,” Slazak says. These chronic healthconditions may include hypertension <strong>and</strong> high cholesterolconcomitant with Type 2 diabetes. “We educ<strong>at</strong>e p<strong>at</strong>ients notonly about the condition itself <strong>and</strong> how to manage it throughnon-pharmacologic tre<strong>at</strong>ment like diet <strong>and</strong> exercise, but alsohow to best use their medic<strong>at</strong>ion to get the best outcomes.”D<strong>at</strong>a for Slazak’s CPS research were collected from 2006 to2007 from Lifetime Health p<strong>at</strong>ients with Type 2 diabetes.A total <strong>of</strong> 122 p<strong>at</strong>ients enrolled <strong>and</strong> received an initial consult<strong>at</strong>ionwith a MedSense pharmacist. Of th<strong>at</strong> number, only50 p<strong>at</strong>ients had sufficient labor<strong>at</strong>ory <strong>and</strong> economic d<strong>at</strong>a toallow for inclusion in the study.P<strong>at</strong>ient d<strong>at</strong>a were obtained from the initial CPS interview<strong>and</strong> from p<strong>at</strong>ients’ electronic medical records. Clinical<strong>and</strong> economic assessments were conducted <strong>at</strong> the six- <strong>and</strong>12-month intervals <strong>of</strong> CPS enrollment; baseline assessmentswere obtained from the most recent medical d<strong>at</strong>a up to amaximum <strong>of</strong> six months before enrollment.Each <strong>of</strong> the 50 p<strong>at</strong>ients formally enrolled in the CPS pilotstudy received diabetes educ<strong>at</strong>ion <strong>and</strong> pharmacotherapeuticregimen review. All clinical recommend<strong>at</strong>ions made to their4


Educ<strong>at</strong>ionThe SoPPS educ<strong>at</strong>es students in pharmacy <strong>and</strong> the pharmaceutical sciences, providing them withthe critical thinking skills to allow them to achieve the desired outcomes <strong>of</strong> drug-rel<strong>at</strong>ed therapy<strong>and</strong> disease management through research <strong>and</strong> clinical intervention.AdmissionsThe Office <strong>of</strong> Admissions <strong>and</strong> Advisement strives to improve <strong>and</strong> enhance our processes from year toyear through innov<strong>at</strong>ion, cre<strong>at</strong>ivity, input, <strong>and</strong> planning. In <strong>2009</strong>-10, we exp<strong>and</strong>ed our in-person interviewsessions to include a longer interview with both a faculty/staff member <strong>and</strong> an alumnus, a detailed campus tour, a p<strong>at</strong>ientcareoriented group activity led by our Dean’s Student Ambassadors, <strong>and</strong> a student social. Our Dean’s Alumni Ambassadorsparticip<strong>at</strong>ed in admissions activities by <strong>at</strong>tending gradu<strong>at</strong>e school recruitment fairs across the country, electronically reviewingadmission applic<strong>at</strong>ions, interviewing, <strong>and</strong> particip<strong>at</strong>ing as speakers for our annual Orient<strong>at</strong>ion <strong>and</strong> White Co<strong>at</strong> Ceremony.With the goal <strong>of</strong> engaging emerging markets, we introduced an active social media presence including a <strong>School</strong> Facebook FanPage, Twitter, YouTube, <strong>and</strong> a Wiki-page. These initi<strong>at</strong>ives, together with many others, continue to have a positive impact on thequality <strong>of</strong> our talented <strong>and</strong> diverse applicant pool, ultim<strong>at</strong>ely allowing us to enroll the best <strong>of</strong> the best in our P1 PharmD class.For <strong>2009</strong>, the <strong>University</strong> <strong>at</strong> <strong>Buffalo</strong> welcomed another highly talented freshman class, with 325 students indic<strong>at</strong>ing pre-pharmacyas their intended major, representing nearly 10 percent <strong>of</strong> the incoming class. UB’s Early Assurance program continues to <strong>of</strong>feroutst<strong>and</strong>ing pre-pharmacy students the opportunity to enter our PharmD pr<strong>of</strong>essional program with a minimum GPA <strong>of</strong> 3.5. Forthe <strong>2009</strong>-<strong>2010</strong> academic year, the median GPA for Early Assurance students accepted into the program was 3.8.Meet the Class <strong>of</strong> 2013Interviewed 250Accepted 125Middle 50th Percentile Science & M<strong>at</strong>h GPA(Biology, Chemistry, Physics, M<strong>at</strong>h) 3.5 – 3.9*Middle 50th Percentile <strong>of</strong> Sum PCATPercentile Score (excluding composite) 380 – 421*In-St<strong>at</strong>e 75%Out-<strong>of</strong>-St<strong>at</strong>e 21%Foreign Citizen 4%Number <strong>of</strong> St<strong>at</strong>es/Provinces Represented 14Females 66%Males 34%2 years or less <strong>of</strong> college 53%3+ years <strong>of</strong> college 6%Bachelor’s degree or higher 41%Average Age 21*The middle 50th percentile reflects those between the25th <strong>and</strong> 75th percentiles.6


Continuing Educ<strong>at</strong>ionOffice <strong>of</strong> Postgradu<strong>at</strong>e Pr<strong>of</strong>essional <strong>and</strong>Continuing Educ<strong>at</strong>ionFiscal Year <strong>2009</strong>-<strong>2010</strong>UB Programs 20UB Certific<strong>at</strong>e Programs 1Home Study Programs 2Cosponsored 8Total 31Degrees Granted (<strong>2009</strong>-10)PharmD 114BS in Pharmaceutical Sciences 13BS/MS in Pharmaceutical Sciences 3MS in Pharmaceutical Sciences 1PhD in Pharmaceutical Sciences 1Total 132Degree Program Enrollment (<strong>2009</strong>-10)P1 Year 125P2 Year 125P3 Year 133P4 Year 112PharmD Subtotal 495BS in Pharmaceutical Sciences 35BS/MS in Pharmaceutical Sciences 4MS in Pharmaceutical Sciences 13PhD in Pharmaceutical Sciences 37Pharmaceutical Sciences Subtotal 89Total Enrollment 584The Department <strong>of</strong> <strong>Pharmacy</strong> Practice, Office <strong>of</strong> Postgradu<strong>at</strong>ePr<strong>of</strong>essional Continuing Educ<strong>at</strong>ion, accredits <strong>and</strong> conductscontinuing pharmacy educ<strong>at</strong>ion programs in support <strong>of</strong>life-long learning. Continuing pr<strong>of</strong>essional development<strong>of</strong>ferings are held live on a local <strong>and</strong> regional scale, <strong>and</strong>web-based <strong>and</strong> homestudy on a n<strong>at</strong>ional <strong>and</strong> intern<strong>at</strong>ionallevel designed to provide reviews <strong>and</strong> upd<strong>at</strong>es <strong>of</strong> drug classes<strong>and</strong> therapies, pharmacy law, <strong>and</strong> emerging technologiesused in pharmacy practice.Exp<strong>and</strong>ing the opportunity for WebEx particip<strong>at</strong>ion, thismodality <strong>of</strong>fers opportunity for alumni <strong>and</strong> preceptors,specifically those out <strong>of</strong> region, to particip<strong>at</strong>e in SoPPS<strong>of</strong>ferings from any area.Over 400 pharmacists this year have taken part in the HIVContinuing Educ<strong>at</strong>ion Online Programs, providing variedlevels <strong>of</strong> training for pharmacists seeking the knowledge <strong>and</strong>skills necessary to assess, counsel <strong>and</strong> manage the medic<strong>at</strong>ions<strong>of</strong> p<strong>at</strong>ients living with HIV infection <strong>and</strong> other commonco-morbidities. The basic p<strong>at</strong>hophysiology <strong>of</strong> HIV <strong>and</strong> pharmacology<strong>of</strong> antiretrovirals are covered in the programs aswell as contemporary issues in p<strong>at</strong>ient management, such asadherence, adverse drug reactions, drug interactions, <strong>and</strong>antiretroviral resistance.The postgradu<strong>at</strong>e <strong>of</strong>fice has brought continuing educ<strong>at</strong>ionprograms to pr<strong>of</strong>essional conferences, designed opportunity forresident <strong>of</strong>ferings <strong>and</strong> accredited inter-pr<strong>of</strong>essional activities.The New York St<strong>at</strong>e Department <strong>of</strong> Health recently implemented(Continued on pg 8)7


Continuing Educ<strong>at</strong>ion(continued)a Medicaid Medic<strong>at</strong>ion Therapy Management (MTM) pilot program designed to helpp<strong>at</strong>ients adhere to medic<strong>at</strong>ion therapy <strong>and</strong> ultim<strong>at</strong>ely improve their therapeuticoutcomes. This pilot program was focused on asthma in the Bronx. The UB SoPPS CE<strong>of</strong>fice designed <strong>and</strong> delivered trainings in New York City within this pilot.Soon to be completed is the new online CE program registr<strong>at</strong>ion webpage, allowingfor multiple program selection, particip<strong>at</strong>ion type, registr<strong>at</strong>ion <strong>and</strong> payment inone transaction.Precepting SoPPS students <strong>of</strong>fers pharmacists the opportunity to gain credits <strong>and</strong> applythose credits towards continuing pharmacy educ<strong>at</strong>ional opportunities. Additionalinform<strong>at</strong>ion on becoming a preceptor can be found by accessing the school’s webpage (www.pharmacy.buffalo.edu) or contacting the Office <strong>of</strong> Experiential Educ<strong>at</strong>ion<strong>at</strong> (716) 645-4799.Continuing Educ<strong>at</strong>ion Programs <strong>and</strong> Symposia08/18/<strong>2009</strong> Staphylococcus aureus Continuing Educ<strong>at</strong>ion Series/Strong Memorial09/13/<strong>2009</strong> Medic<strong>at</strong>ion Errors <strong>2009</strong> in <strong>Buffalo</strong>10/27/<strong>2009</strong> Staphylococcus aureus Continuing Educ<strong>at</strong>ion Series/BGH11/04/<strong>2009</strong> Staphylococcus aureus Continuing Educ<strong>at</strong>ion Series/RPCI11/07/<strong>2009</strong> Medic<strong>at</strong>ion Errors <strong>2009</strong> in Albany11/08/<strong>2009</strong> Medic<strong>at</strong>ion Errors <strong>2009</strong> in Rochester11/15/<strong>2009</strong> Pharmacist Educ<strong>at</strong>ors in Ambul<strong>at</strong>ory Antihypertensive TherapyManagement: Prescriber Educ<strong>at</strong>ion Program11/16/<strong>2009</strong> Pharmacist Educ<strong>at</strong>ors in Ambul<strong>at</strong>ory Antihypertensive TherapyManagement: Prescriber Educ<strong>at</strong>ion Program12/06/<strong>2009</strong> MRSA: New Challenges <strong>and</strong> Approaches01/01/<strong>2010</strong> <strong>Pharmacy</strong>-Based Immuniz<strong>at</strong>ion Delivery01/27/<strong>2010</strong> Cased Based Clinical Upd<strong>at</strong>e… An Integr<strong>at</strong>ed Case-Based Approach02/21/<strong>2010</strong> Ophthalmology Part 1: Self-Tre<strong>at</strong>ment <strong>of</strong> Ophthalmic Conditions03/07/<strong>2010</strong> Ophthalmology Part II: Pharmacotherapeutic Management <strong>of</strong> PrimaryOpen Angle Glaucoma <strong>and</strong> Primary Angle-Closure Glaucoma03/21/<strong>2010</strong> Ophthalmology Part III: Pharmacotherapeutic Management <strong>of</strong> DryEye Syndrome03/23/<strong>2010</strong> Teaching, Learning, <strong>and</strong> the Preceptorship: A Review <strong>of</strong> the Research03/28/<strong>2010</strong> <strong>Pharmacy</strong> Law Upd<strong>at</strong>e <strong>2010</strong> in Rochester04/11/<strong>2010</strong> <strong>Pharmacy</strong> Law Upd<strong>at</strong>e <strong>2010</strong> in <strong>Buffalo</strong>04/29/<strong>2010</strong> HIV Upd<strong>at</strong>e Symposium <strong>2010</strong>05/12/<strong>2010</strong> Clinical <strong>Pharmacy</strong> Service05/19/<strong>2010</strong> 15th Annual Comprehensive <strong>Pharmacy</strong> Law Continuing Educ<strong>at</strong>ionfor Pharmacists (Day 1)05/20/<strong>2010</strong> 15th Annual Comprehensive <strong>Pharmacy</strong> Law Continuing Educ<strong>at</strong>ionfor Pharmacists (Day 2)06/23/<strong>2010</strong> <strong>Pharmacy</strong>-Based Immuniz<strong>at</strong>ion DeliveryOngoing: Online-Introductory HIV Pharmaceutical Care Specialist ProgramOngoing: Online-HIV Pharmacotherapy CE Upd<strong>at</strong>eOngoing: Online-HIV Annual Upd<strong>at</strong>e CEResidency Training ProgramSummary <strong>2009</strong>-10The Department <strong>of</strong> <strong>Pharmacy</strong> Practice maintainedits commitment to providing post-gradu<strong>at</strong>e educ<strong>at</strong>ionthrough general (PGY-1) <strong>and</strong> specialty (PGY-2)residency training. During the <strong>2009</strong>-10 academicyear, our residency program consisted <strong>of</strong> four PGY-1programs; two ambul<strong>at</strong>ory care / primary care, oneinp<strong>at</strong>ient, <strong>and</strong> one in hospice/palli<strong>at</strong>ive care. Ourprogram also <strong>of</strong>fered three PGY-2 programs; HIV,psychi<strong>at</strong>ry, <strong>and</strong> inform<strong>at</strong>ics. We are pleased to reportwe had two residency programs reaccredited:PGY1 <strong>Pharmacy</strong> Practice/Family Medicine <strong>at</strong> ErieCounty Medical Center <strong>and</strong> PGY1 Ambul<strong>at</strong>ory Care<strong>Pharmacy</strong> Practice <strong>at</strong> Lifetime Health.Our mission, to educ<strong>at</strong>e pharmacy residents inpharmacy practice, clinical precepting, didacticteaching, clinical research <strong>and</strong> manuscript writing;to provide p<strong>at</strong>ient care; <strong>and</strong> to provide services tothe community <strong>at</strong> large based upon this knowledge,with the goal <strong>of</strong> training pharmacy residents topractice autonomously in the clinical pharmacy<strong>and</strong>/or academic settings, sets the framework forour program.The goals <strong>of</strong> our program are accomplished byinvolving our residents in clinical activities, researchprojects, <strong>and</strong> teaching. Specifically, our residentsparticip<strong>at</strong>e in a unique didactic research course,<strong>at</strong>tend an established teaching certific<strong>at</strong>e program,actively particip<strong>at</strong>e in small <strong>and</strong> large group didacticteaching <strong>and</strong> clinical precepting, present an ACPEaccredited CE program, <strong>and</strong> conduct a researchproject. The <strong>University</strong> <strong>at</strong> <strong>Buffalo</strong> <strong>School</strong> <strong>of</strong> <strong>Pharmacy</strong>sponsors an annual Residency Present<strong>at</strong>ion Day,which continued to exp<strong>and</strong> in <strong>2010</strong>, <strong>and</strong> now includesmultiple residency programs from the Western NewYork, Rochester, <strong>and</strong> Syracuse area.8


Student Achievements<strong>2010</strong> Celebr<strong>at</strong>ion <strong>of</strong> AcademicExcellence Student ResearchPoster PresentersRyan CummingsJorge GallegosSean LeeCarrie SanbornAndrew TongCharles VenutoAmy ZhouJian Li Zhu<strong>2010</strong> SoPPS Student ResearchPoster WinnersBS <strong>and</strong> BS/MSFirst place: Amy DotySecond place: Sean LeThird place: Jian Li ZhuP3 StudentsFirst place: Gauri RaoSecond-place tie: Angela Mwaura& Dung NgoP4 StudentFirst place: K<strong>at</strong>ie JaeneckeAmerican Associ<strong>at</strong>ion <strong>of</strong>Colleges <strong>of</strong> <strong>Pharmacy</strong>Pruitt-Schutte Business PlanCompetition, 4th Place Team MembersMike Grota, Danielle Kauffman,Mir<strong>and</strong>a Minhas <strong>and</strong> VikramSundararamanAmerican Pharmacists Associ<strong>at</strong>ionAcademy <strong>of</strong> Student PharmacistsMembers Develop Video Showing theImportance <strong>of</strong> <strong>Pharmacy</strong> in HealthCare ReformDrew Lambert, Michael Krajewski,Oluwa Fabiyi, Kristen Zeitler, JamieChin, Gauri Rao <strong>and</strong> Jason HouIndividual AchievementsSamuel Aitken recipient <strong>of</strong><strong>2010</strong> American Associ<strong>at</strong>ion <strong>of</strong>Colleges <strong>of</strong> <strong>Pharmacy</strong> <strong>and</strong>WalMart Scholars ProgramsSuraj Bhansali recipient <strong>of</strong> theAmerican College <strong>of</strong> Clinical PharmacologyStudent/Trainee Awardfor his abstract: “Development <strong>of</strong>Physiological Based PharmacokineticModel to Predict TissueDistribution <strong>of</strong> Vascular EndothelialGrowth Factor C156S”Caitlin Carpenter recipient <strong>of</strong>the Pharmacists’ Associ<strong>at</strong>ion <strong>of</strong>Western New York Owl Drugs/Donald Arthur, Sr. EntrepreneurialScholarshipChristopher Daly recipient <strong>of</strong>the Pharmacists’ Associ<strong>at</strong>ion <strong>of</strong>Western New York Golf Scholarship<strong>and</strong> is a recipient <strong>of</strong> the <strong>2010</strong>U.S. Public Health Service Excellencein Public Health <strong>Pharmacy</strong>Practice AwardGertrude Chimhungwe recipient<strong>of</strong> a <strong>2009</strong> N<strong>at</strong>ional Community<strong>Pharmacy</strong> Associ<strong>at</strong>ion Found<strong>at</strong>ionPresidential ScholarshipK<strong>at</strong>herine DiPalo has beenaccepted into the Veteran’sAdministr<strong>at</strong>ion VALOR Program<strong>at</strong> the <strong>Buffalo</strong> Veterans Administr<strong>at</strong>ionMedical Center. VALOR<strong>of</strong>fers a paid internship <strong>and</strong> givesqualified students the opportunityto develop clinical practicecompetencies under the guidance<strong>of</strong> a preceptorKristen Gawronski recipient <strong>of</strong>a <strong>2009</strong> N<strong>at</strong>ional Community<strong>Pharmacy</strong> Associ<strong>at</strong>ion Found<strong>at</strong>ionStudent Chapter Outst<strong>and</strong>ingMembers <strong>of</strong> the Year AwardDavid Jacob recipient <strong>of</strong> <strong>2010</strong>American Associ<strong>at</strong>ion <strong>of</strong> Colleges<strong>of</strong> <strong>Pharmacy</strong> <strong>and</strong> WalMart ScholarsProgramsLindsay Rodgers recipient <strong>of</strong> the<strong>Buffalo</strong> Feder<strong>at</strong>ion <strong>of</strong> WomenScholarshipCaitlin Turner recipient <strong>of</strong> the<strong>2009</strong> RX Portfolio N<strong>at</strong>ionalAchievement AwardCharles Venuto recipient <strong>of</strong> the<strong>2010</strong> Daniel H. Murray Pr<strong>of</strong>essionalDevelopment AwardKristen Zeitler selected as a member<strong>of</strong> the American PharmacistsAssoci<strong>at</strong>ion- Academy <strong>of</strong> Students<strong>of</strong> <strong>Pharmacy</strong> (APhA-ASP) PolicySt<strong>and</strong>ing Committee. She is alsothe recipient <strong>of</strong> Pharmacists’Associ<strong>at</strong>ion <strong>of</strong> Western New YorkHoward <strong>and</strong> Bee Scholarship<strong>and</strong> the <strong>2010</strong> Respect, Excellence<strong>and</strong> Service in <strong>Pharmacy</strong> StudentAward<strong>2009</strong>-10 Degree RecipientsBachelor <strong>of</strong> Sciencein PharmaceuticalSciencesSeptember <strong>2009</strong>Anas F<strong>at</strong>hallahMehwish GhauriFebruary <strong>2010</strong>Nabeel KhanJune <strong>2010</strong>Jennifer BiernackiRyan CummingsAmy DotyM<strong>at</strong>thew FranchiniJorge GallegosSean Guang LeeJian Hui LiuGenki NakamuraLong Kim NguyenTina TsangPrince YeboahBachelor <strong>of</strong> Science/Master <strong>of</strong> Sciencein PharmaceuticalSciencesSeptember <strong>2009</strong>Diana MolanoJrace RongFebruary <strong>2010</strong>Eun Jin BangGhislaine Ngo MbongJune <strong>2010</strong>JiHye LeeDoctor <strong>of</strong> <strong>Pharmacy</strong>June <strong>2010</strong>Victoria AdamsK<strong>of</strong>i AdjeiAnn Marie AndrasikMonika BaltaziukSarah B<strong>and</strong>inelliAnuoluwapoBank-OniJulie BannisterMichael BartelsMichael BevilacquaHe<strong>at</strong>her Br<strong>and</strong>Andrea BreyerKirsten ButterfossMarianne CaciciaK<strong>at</strong>herine CarloughAndrea CarlsonSusan ChangQueena ChenNicole CieriAmy ColbyTravis DangeloSarah DavisAnna DecolongonRachel DeppasNghi DinhJames DiNicolantonioPhilip EisenbergSusana EngNicholas FalcoMadlin FariaGraziella FurnariNicholas FuscoJoseph GajewskiKaitlyn GanleyKristen GawronskiLisa GeorgeHany GerisBrian GielowskiGregory GotieN<strong>at</strong>alie GraiverGary GrecoJennifer GremkeAshley HughesJesse ImesK<strong>at</strong>ie JaeneckeKavita JainJessica JarnotJill JessmerJamie KaminskiBrian KerstenErin KnightSaneel KulkarniHayley Kwi<strong>at</strong>Zhibin LaiDechen LamaTshering LamaThomas L<strong>at</strong>ugaShirley LauLisa LederhouseChristopher LeeKyung Na LeePeggy LeeTeresa LiKristen LimLauren LimDong LiuWing LiuLaurie LoedemanMelissa MackeyMiroslavaM<strong>and</strong>roshchukGiuseppe MarinoBethany MarkertStephen MeyersChristopher MillerMir<strong>and</strong>a MinhasBrett MohorcicAlex MoralesDana NerenbergLea NitcheAzaliah O’BanyounEmily ObristPamela OlbrychSeon Jo ParkVivian ParkAmisha P<strong>at</strong>elChristopher PoonBrenda QueenoBasant RiwesKeith RoweSonia SawkarDavid SeelmanNida SiddiqiAm<strong>and</strong>a SkinnerKari SproutBrian StaigerDeanna StengelTiffany StevensCaroline SuczynskiElizabeth SuttonJennifer TaggartSiuBun TangPeggy TapiaChristopher TerranceAndrew TongKim Sang TranN<strong>at</strong>alie Travagli<strong>at</strong>oCharles VenutoN<strong>at</strong>haniel WadeBrian WetzelSierra WolfordChung WongPhillip WongTrevor YannaceDavid YeowErica ZakDoctor <strong>of</strong> Philosophyin PharmaceuticalSciencesSeptember <strong>2009</strong>Xinning YangFebruary <strong>2010</strong>Anu Krishn<strong>at</strong>ryUrvi TelangJune <strong>2010</strong>Anson AbrahamDhavalkumar Shah11


Research <strong>and</strong> TrainingCre<strong>at</strong>e cutting edge research th<strong>at</strong> enhances the body <strong>of</strong> knowledge needed for pr<strong>of</strong>essionaleduc<strong>at</strong>ion, healthcare delivery, <strong>and</strong> advancement <strong>of</strong> sciences th<strong>at</strong> will improve the health <strong>and</strong>wellness <strong>of</strong> the global community.Department <strong>of</strong> Pharmaceutical SciencesOur department has a well established, intern<strong>at</strong>ional reput<strong>at</strong>ion for a tradition <strong>of</strong> excellence in teaching<strong>and</strong> research <strong>and</strong> is well positioned to exp<strong>and</strong> its prowess in Pharmacokinetics, Pharmacodynamics, <strong>and</strong>Protein Therapeutics.Moreover, the department is a leading academic institute forcutting edge research <strong>and</strong> teaching in Pharmacogenomics.The department strengths lie in biological applic<strong>at</strong>ions <strong>of</strong>pharmaceutical sciences to traditional small molecules as wellas biotechnology products, particularly areas <strong>of</strong> systems pharmacology(pharmacokinetics, pharmacodynamics, pharmacogenomics),drug delivery, <strong>and</strong> development <strong>of</strong> new therapeuticapproaches utilizing mechanistic studies with tools <strong>of</strong> genomics,proteomics, comput<strong>at</strong>ion, <strong>and</strong> bioinform<strong>at</strong>ics.Of special note were the activities <strong>of</strong> the Center for ProteinTherapeutics, directed by Dr. Joseph P. Balthasar. Withadditional major input from Drs. William Jusko, MarilynMorris, <strong>and</strong> Donald Mager, <strong>and</strong> particip<strong>at</strong>ion by several othermembers <strong>of</strong> the department, the Center seeks to apply ourcapabilities in pharmacokinetics, pharmacodynamics, proteinanalysis, <strong>and</strong> protein formul<strong>at</strong>ion, <strong>and</strong> to address majorquestions regarding the delivery, pharmacokinetics, <strong>and</strong> in vivoeffects <strong>of</strong> protein drugs such as monoclonal antibodies. Researchsites are <strong>at</strong> the Center <strong>of</strong> Excellence in Bioinform<strong>at</strong>ics <strong>and</strong> LifeSciences in the medical corridor as well as in the Cooke-Hochstetter Building on the North Campus. Financialsupport <strong>of</strong> $1.35 million for the third year <strong>of</strong> research <strong>and</strong>training by the Center was provided by Abbott, Boehringer-Ingelheim, Eli Lilly, Genentech, H<strong>of</strong>fman-LaRoche, Merck,Pfizer, as well as additional rel<strong>at</strong>ed funding provided byNovartis <strong>and</strong> Amgen.We have excellent faculty members over a range <strong>of</strong> academiclevels with highly productive, largely NIH-funded researchprograms <strong>and</strong> some corpor<strong>at</strong>e support. Don<strong>at</strong>ions <strong>of</strong> over$150,000 for gradu<strong>at</strong>e student training were provided by EliLilly, Daiichi Sankyo, Schering-Plough, <strong>and</strong> Amgen, <strong>and</strong> as wellas continued funding <strong>of</strong> a training grant for $500,000 tosupport 6 students <strong>and</strong> 4 post-doctoral fellows by PfizerPharmaceuticals. Dr. Robert Straubinger was successful inobtaining funding for a new LC/MS/MS Instrument to augmentour bioanalytical capabilities.An active Seminar Program was <strong>of</strong>fered with over 25 present<strong>at</strong>ionsby local <strong>and</strong> visiting scientists. Dr. Malcolm Rowl<strong>and</strong>,Pr<strong>of</strong>essor <strong>and</strong> Dean Emeritus <strong>at</strong> the <strong>University</strong> <strong>of</strong> Manchesterin the United Kingdom was selected for the <strong>2009</strong> GerhardLevy Distinguished Lectureship in Pharmaceutical Sciences.His present<strong>at</strong>ion was entitled, “Physiologically-Based Pharmacokinetics:Moving the Big Picture Forward.” Other notablespeakers during the academic year were: Dr. Bradley Andersonfrom the <strong>University</strong> <strong>of</strong> Kentucky, Dr. Doanh Tran from the FDA,Dr. Micheline Piquette from the <strong>University</strong> <strong>of</strong> Toronto, <strong>and</strong>Dr. Carol Lim from the <strong>University</strong> <strong>of</strong> Utah. The Twelfth <strong>Buffalo</strong>Pharmaceutics Symposium was held in July with gre<strong>at</strong> success.Alumni from the US, Europe, Japan, <strong>and</strong> Australia <strong>at</strong>tended.Notable visiting speakers included: Dr. Alison Betts from Pfizer,Dr. Yuichi Sugiyama from the <strong>University</strong> <strong>of</strong> Tokyo, Dr. Jean-Michel Scherrmann from the <strong>University</strong> <strong>of</strong> Paris, Dr. StevenHansel from Pfizer, Dr. Gordon Amidon from the <strong>University</strong><strong>of</strong> Michigan, Dr. Lisa Benincosa from H<strong>of</strong>fman-LaRoche,Dr. Lawrence Lesko from the FDA, Dr. YoungJin Moon fromthe FDA, along with several present<strong>at</strong>ions by departmentalfaculty members, fellows, <strong>and</strong> students. Our social event <strong>at</strong>the <strong>Buffalo</strong> Zoo did not traum<strong>at</strong>ize the animals too badly.Our department faculty members were active in dissemin<strong>at</strong>ion<strong>of</strong> our scientific accomplishments <strong>and</strong> knowledge. We had82 research articles <strong>and</strong> book chapters published <strong>and</strong> gave84 seminars, lectures, <strong>and</strong> research present<strong>at</strong>ions <strong>at</strong> variousscientific meetings, university <strong>and</strong> industrial venues.The department <strong>of</strong>fers annual courses in Pharmacokinetic-Pharmacodynamic Modeling, Protein Therapeutics, <strong>and</strong> Popul<strong>at</strong>ionPharmacokinetic Modeling for visiting scientists from thepharmaceutical industry, academia, <strong>and</strong> the FDA. In May we werepleased to <strong>of</strong>fer our 18th session <strong>of</strong> the PK/PD Modeling course.Similarly, the department <strong>of</strong>fers an annual summer workshop inMolecular Genetic Methodologies for Pharmaceutical Sciences.Some <strong>of</strong> these courses are also provided on site <strong>at</strong> variouspharmaceutical companies <strong>and</strong> other universities.12


Dr. Joseph Balthasar received the “Outst<strong>and</strong>ing Manuscriptin Modeling <strong>and</strong> Simul<strong>at</strong>ion” Award from the AmericanAssoci<strong>at</strong>ion <strong>of</strong> Pharmaceutical Scientists in November <strong>2009</strong> fordeveloping an innov<strong>at</strong>ive spherical tumor model to describedrug penetr<strong>at</strong>ion. Dr. S<strong>at</strong>hy Balu-Iyer was nomin<strong>at</strong>ed forInventor <strong>of</strong> the Year Award in <strong>2010</strong> for his p<strong>at</strong>ents rel<strong>at</strong>ed tolipidized proteins.The department is poised for further growth <strong>of</strong> its research<strong>and</strong> training programs. We added Dr. Jun Qu as a facultymember in the area <strong>of</strong> bioanalytics <strong>and</strong> proteomics <strong>and</strong> areseeking to exp<strong>and</strong> capabilities in the areas <strong>of</strong> Protein Therapeutics,Cancer Therapeutics, <strong>and</strong> Pharmacogenomics.Department <strong>of</strong> <strong>Pharmacy</strong> PracticeThe <strong>2009</strong>-10 academic year was a robust <strong>and</strong> productive yearfor the Department <strong>of</strong> <strong>Pharmacy</strong> Practice. The teaching <strong>and</strong>research <strong>of</strong> the faculty continued to increase within the PharmDprogram as well as with our postgradu<strong>at</strong>e training programs.Two <strong>of</strong> our residency programs underwent reaccredit<strong>at</strong>ionthis year <strong>and</strong> the department is continually assessing all trainingprograms to meet future accredit<strong>at</strong>ion needs.Our faculty members represented the school well <strong>at</strong> manyn<strong>at</strong>ional meetings. At the <strong>2009</strong> American Associ<strong>at</strong>ion <strong>of</strong> Colleges<strong>of</strong> <strong>Pharmacy</strong> meeting, many faculty members <strong>at</strong>tended <strong>and</strong>particip<strong>at</strong>ed in poster present<strong>at</strong>ions, seminars <strong>and</strong> groupdiscussion topics. Drs. Gene Morse <strong>and</strong> Linda C<strong>at</strong>anzaro,along with Pr<strong>of</strong>essor Karl Fiebelkorn, are lead authors in thedevelopment <strong>of</strong> the Business Model submission ‘Developinga Bioinform<strong>at</strong>ics <strong>and</strong> Medic<strong>at</strong>ion Management ResearchNetwork’ published by the California Pharmacists Associ<strong>at</strong>ion.Also <strong>of</strong> note was n<strong>at</strong>ional press <strong>at</strong>tention garnered by Drs. ErinSlazak <strong>and</strong> Scott Monte for their recent diabetes study showingthe positive impact pharmacists have in enhancing p<strong>at</strong>ientcare, while decreasing health care costs.The department is proud <strong>of</strong> the continued collabor<strong>at</strong>ion withthe New York St<strong>at</strong>e Department <strong>of</strong> Health. Activities havecontinued to grow <strong>and</strong> exp<strong>and</strong> with involvement in a pilotMedic<strong>at</strong>ion Therapy Management Program, st<strong>at</strong>ewide drugutiliz<strong>at</strong>ion review <strong>and</strong> a novel prescriber educ<strong>at</strong>ion program(PEP). These efforts, in collabor<strong>at</strong>ion with other SUNY healthscience units, are expected to provide much benefit to New YorkSt<strong>at</strong>e Medicaid recipients <strong>and</strong> provide excellent opportunitiesfor our faculty <strong>and</strong> students to engage in pharmacoeconomic<strong>and</strong> pharmacoinform<strong>at</strong>ic scholarly activities.The Office <strong>of</strong> Experiential Educ<strong>at</strong>ion has continued to meetthe ever increasing dem<strong>and</strong>s for rot<strong>at</strong>ional sites for our P1-P4students. The Experiential Program has exp<strong>and</strong>ed the depth<strong>and</strong> breadth <strong>of</strong> rot<strong>at</strong>ional opportunities for P1-P3 students <strong>and</strong>has also exp<strong>and</strong>ed P4 opportunities throughout the country.The implement<strong>at</strong>ion <strong>of</strong> new scheduling <strong>and</strong> managements<strong>of</strong>tware has cre<strong>at</strong>ed efficiencies in rot<strong>at</strong>ional scheduling <strong>and</strong>reporting. Faculty Development programs continue to exp<strong>and</strong><strong>and</strong> grow.13


Faculty Grants AwardedJuly 1, <strong>2009</strong> - June 30, <strong>2010</strong>Pharmaceutical SciencesJoseph BalthasarN<strong>at</strong>ional Heart Lung & Blood Institute (Balu-Iyer Co-PI)Pharmacology <strong>and</strong> Bioengineering <strong>of</strong> New Tre<strong>at</strong>ments <strong>of</strong> ITPMultiple SponsorsProtein Therapeutics ConsortiumN<strong>at</strong>ional Cancer Institute (D. Brazeau Co-PI)Pharmacokinetic Str<strong>at</strong>egies to Optimize IP Chemotherapy<strong>University</strong> <strong>of</strong> MichiganPTD-Medi<strong>at</strong>ed Protein <strong>of</strong> Drug Delivery for Cancer TherapyS<strong>at</strong>hy Balu-IyerN<strong>at</strong>ional Heart Lung & Blood Institute (Balthasar Co-PI)Development <strong>and</strong> Pharmacology <strong>of</strong> Novel Lipidic RAHFN<strong>at</strong>ional Cancer Institute (Co-PI)Re-activ<strong>at</strong>ing Memory T cells in Microenvironment <strong>of</strong>Human TumorsJavier BlancoN<strong>at</strong>ional Institute <strong>of</strong> General Medical Sciences (RO1)Pharmacogenetics <strong>of</strong> Human Carbonyl ReductasesN<strong>at</strong>ional Institute <strong>of</strong> General Medical SciencesARRA: Pharmacogenetics <strong>of</strong> Human Carbonyl ReductasesCity <strong>of</strong> Hope N<strong>at</strong>ional Medical CenterAdverse Events After Childhood Hem<strong>at</strong>ologic Malignancies:Role <strong>of</strong> Genetic SusceptibilityDaniel BrazeauN<strong>at</strong>ional Institute on Deafness <strong>and</strong> other Communic<strong>at</strong>ionDisorders (Co-PI)Noise-Induced Acute Hair Cell De<strong>at</strong>hHo-Leung FungN<strong>at</strong>ional Heart Lung & Blood Institute (D. Brazeau Co-PI)Organic Nitr<strong>at</strong>e Metabolism, Tolerance <strong>and</strong> ActionWilliam JuskoN<strong>at</strong>ional Institute <strong>of</strong> General Medical SciencesCorticosteroid Pharmacokinetics <strong>and</strong> PharmacodynamicsN<strong>at</strong>ional Institute <strong>of</strong> General Medical Sciences (Mager &Krzyanski Co-PI’s)M<strong>at</strong>hem<strong>at</strong>ical Models in PharmacodynamicsPfizer, Inc.Pfizer PKPD FellowshipsNOVO Nordisk Pharmaceuticals Inc.Ethnic Differences in Type 2 DiabetesDonald MagerH<strong>of</strong>fmann LaRoche, Inc.Modeling <strong>of</strong> the Pharmacokinetics <strong>of</strong> TDM1 Using aMechanism-Based ApproachFred Hutchinson Cancer Research CenterPopul<strong>at</strong>ion Pharmacokinetics/Pharmacodynamics inNonabl<strong>at</strong>ive Stem Cell RecipientsN<strong>at</strong>ional Institute on Drug Abuse (Co-PI)Innov<strong>at</strong>ive Nanotherapy for Drug AddictionMarilyn MorrisN<strong>at</strong>ional Institute on Drug AbuseGamma-Hydroxbutyr<strong>at</strong>e: Toxicokinetics, Toxicodynamics <strong>and</strong>Tre<strong>at</strong>ment Str<strong>at</strong>egiesSusan G. Komen Breast CenterMultiple Flavonoids in the Tre<strong>at</strong>ment <strong>of</strong> Multidrug ResistanceJun QuN<strong>at</strong>ional Heart Lung <strong>and</strong> Blood Institute (Co-PI)Metabolic Adapt<strong>at</strong>ion <strong>and</strong> Functional Recovery <strong>of</strong>Hibern<strong>at</strong>ing MyocardiumHealth Research Inc. (Straubinger Co-PI)PSA-Proteomic Analysis <strong>of</strong> RB-Associ<strong>at</strong>ed ProteinsN<strong>at</strong>ional Institutes <strong>of</strong> Allergy <strong>and</strong> Infections (Co-PI)ARRA: P<strong>at</strong>hogenesis <strong>of</strong> Moraxella C<strong>at</strong>arrhalis in ChronicObstuctive Pulmonary DiseaseN<strong>at</strong>ional Institutes <strong>of</strong> Allergy <strong>and</strong> Infections (Co-PI)Protein Arginine Methyl<strong>at</strong>ion in TrypanosomesMurali Raman<strong>at</strong>hanN<strong>at</strong>ional Multiple Sclerosis SocietyBrain-Derived Neurotrophic Factor in Multiple SclerosisRobert StraubingerN<strong>at</strong>ional Center for Research Resources (Fung Co-PI)ARRA: Circular Dichroism Spectropolarimeter withFluorescence Acquisition <strong>and</strong> Temper<strong>at</strong>ure ControlHealth Research, Inc.CCPD-1: Proteomics <strong>and</strong> Biopharmaceutical Analysisin Support <strong>of</strong> Transl<strong>at</strong>ional Cancer ResearchN<strong>at</strong>ional Institute on Drug Abuse (Qu Co-PI)Peripheral Biomarkers <strong>of</strong> Cocaine Dependence <strong>and</strong>RelapseAiming YuN<strong>at</strong>ional Institute on Drug Abuse (Jusko & Boje Co-PI’s)Pharmacogenetics in Indolealkylamine Metabolism <strong>and</strong>Drug InteractionsNew TechnologyInvention DisclosuresInvention TitleAn Inline Urinary Monitoring Device with a Multi-SensorArray Suitable for Continuous Monitoring <strong>of</strong> BiologicalConditions Reflexive <strong>of</strong> Health <strong>and</strong> DiseaseA Method <strong>of</strong> Diabetes Tre<strong>at</strong>ment Using the Process <strong>of</strong>Biomarker Measurement with the System <strong>of</strong> a Supply-SideTre<strong>at</strong>ment Algorithm as a Method to Provide PersonalizedPharmaceutical Compositions <strong>and</strong> DosagesA Method <strong>of</strong> Diabetes Tre<strong>at</strong>ment Using the Process <strong>of</strong>Biomarker Measurement with the System <strong>of</strong> a Supply-SideTre<strong>at</strong>ment Algorithm as a Method to Provide PersonalizedPharmaceutical Compositions <strong>and</strong> DosagesFaculty MemberJerome SchentagJerome SchentagScott Monte14


Issued P<strong>at</strong>entsP<strong>at</strong>ent Title<strong>Pharmacy</strong> PracticeGayle BrazeauH<strong>of</strong>fman LaRoche, Inc.Formul<strong>at</strong>ion Approaches for Minimizing Injection Site Reactions:In VIVO <strong>and</strong> in Vitro StudiesAlice CeacareanuNYS Council <strong>of</strong> Health-System PharmacistsEvalu<strong>at</strong>ing the Prognostic Value <strong>of</strong> Adiponectin Levels inDiabetics with Breast Cancer: Role <strong>of</strong> Insulin SensitizersNYS Council <strong>of</strong> Health-System Pharmacists (Dr. Alan Forrest Co-PI)Diabetes Pharmacotherapy in Breast Cancer: Quo Vadis?NYS Department <strong>of</strong> HealthModul<strong>at</strong>ion <strong>of</strong> Inflamm<strong>at</strong>ory Response by DiabetesManagement in Breast Cancer P<strong>at</strong>ients: a Potential Modifier<strong>of</strong> Breast Cancer Prognosis<strong>University</strong> <strong>of</strong> PittsburghOptomizing Dosing <strong>of</strong> Colistin for Infections Resistantto all Other AntibioticsMethod <strong>of</strong> Complexing a Protein by the Use <strong>of</strong> aDispersed System <strong>and</strong> Proteins There<strong>of</strong>Method <strong>of</strong> Complexing a Protein by the Use <strong>of</strong> aDispersed System <strong>and</strong> Proteins There<strong>of</strong>Anti-FcRn Antibodies for Tre<strong>at</strong>ment <strong>of</strong> Auto/AlloImmune ConditionsCompositions <strong>and</strong> Methods <strong>of</strong> Prepar<strong>at</strong>ion <strong>of</strong>Liposomal Microparticul<strong>at</strong>e Il-12 for ImmunotherapyFaculty MemberS<strong>at</strong>hy Balu-IyerRobert StraubingerJoseph BalthasarS<strong>at</strong>hy Balu-IyerGene Morse<strong>University</strong> <strong>of</strong> RochesterTargeted Neuro Protection <strong>of</strong> HIV-1 Associ<strong>at</strong>ed NeurologicDiseaseErie County Medical CenterHIV Tre<strong>at</strong>ment Educ<strong>at</strong>ionErie County Medical CenterAdherence ProjectFogarty Intern<strong>at</strong>ional Center (Drs. Ma <strong>and</strong> Maponga Co-PI’s)Antiretroviral Pharmacology Training in Resource PoorCountriesSocial <strong>and</strong> Scientific Systems, Inc.AACTG Pharmacology Labor<strong>at</strong>oryN<strong>at</strong>ional Institute <strong>of</strong> Allergy & Infectious DiseaseClinical Pharmacology Quality Assurance <strong>and</strong> Quality Control<strong>University</strong> <strong>of</strong> RochesterUpst<strong>at</strong>e New York Transl<strong>at</strong>ional Research Network<strong>University</strong> <strong>of</strong> RochesterCenter for Experimental Therapeutics<strong>University</strong> <strong>of</strong> RochesterUnits for HIV/Aids Clinical Trials Network<strong>University</strong> <strong>of</strong> RochesterUnits for HIV/Aids Clinical Trials Network: EquipmentWashington <strong>University</strong>, St. LouisNeurologic Aids Research Consortium<strong>University</strong> <strong>of</strong> California, San Francisco (Dr. Ma Co-Pl)Disulfiram Interactions with HIV Medic<strong>at</strong>ions: Clinical Implic<strong>at</strong>ionsK<strong>at</strong>hleen Torn<strong>at</strong>oreN<strong>at</strong>ional Institute Diabetes & Digestive & Kidney Disease(D. Brazeau Co-PI)ARRA: Genomic <strong>and</strong> Cellular Markers <strong>and</strong> Chronic RenalAllograft FunctionNovartis Pharmaceuticals Corpor<strong>at</strong>ionThe Rel<strong>at</strong>ionship <strong>of</strong> Drug Exposure <strong>and</strong> ImmunodynamicResponses During Myfortic Therapy in Stable African American<strong>and</strong> Caucasion Renal Transplant P<strong>at</strong>ientsDr. Brian TsujiMonash <strong>University</strong> (Dr. Alan Forrest Co-PI)Targeting MDR Hetero-Resistant Gram-Neg<strong>at</strong>ives: PK/PD forR<strong>at</strong>ional Combin<strong>at</strong>ionsCubist PharmaceuticalsAntimicrobial Pharmacodynamics <strong>of</strong> a Novel Investig<strong>at</strong>ionalLipopetide Against S. AureusPfizer PharmaceuticalsImpact <strong>of</strong> Linezilid on the Accessory Gene Regul<strong>at</strong>or System<strong>of</strong> Staphylococcus Aureaus by Pr<strong>of</strong>iling PharmacodynamicsAlbany College <strong>of</strong> <strong>Pharmacy</strong> <strong>and</strong> Health SciencesEpidemiology <strong>of</strong> Vancomycin Susceptibility PhenotypesAssoci<strong>at</strong>ed with Suboptimal Clinical Outcomes AmongP<strong>at</strong>ients with MRSA bloodstream infections in Upst<strong>at</strong>eNew YorkRobert WahlerCommunity Health Found<strong>at</strong>ion <strong>of</strong> WCNYMedic<strong>at</strong>ion Management for Older Adults15


ScholarshipPursue innov<strong>at</strong>ion, identify solutions <strong>and</strong> present resultsto enhance the local, n<strong>at</strong>ional <strong>and</strong> intern<strong>at</strong>ional leadership<strong>of</strong> SUNY, UB <strong>and</strong> the SoPPS.Intellectual ContributionsJuly 1, <strong>2009</strong> - June 30, <strong>2010</strong>Pharmaceutical SciencesBalthasar, Joseph P.Urva, S. R., Yang, V. C., & Balthasar, J. P. (<strong>2010</strong>). Physiologicallybased pharmacokinetic model for T84.66, a monoclonal anti-CEAantibody. Journal <strong>of</strong> Pharmaceutical Sciences, 99(3), 1582-1600.Urva, S. R., Yang, V. C., & Balthasar, J. P. (<strong>2010</strong>). An ELISA forquantific<strong>at</strong>ion <strong>of</strong> T84.66, a monoclonal anti-CEA antibody, inmouse plasma. J Immunoassay Immunochem, 31(1), 1-9.Urva, S. R., & Balthasar, J. P. (<strong>2010</strong>). Target medi<strong>at</strong>ed disposition<strong>of</strong> T84.66, a monoclonal anti-CEA antibody: applic<strong>at</strong>ion in thedetection <strong>of</strong> colorectal cancer xenografts. Mabs, 2(1), 67-72.Garg, A., & Balthasar, J. P. (<strong>2009</strong>). Investig<strong>at</strong>ion <strong>of</strong> the influence<strong>of</strong> FcRn on the distribution <strong>of</strong> IgG to the brain. AAPS Journal,11(3), 553-557.Urva, S. R., Yang, V. C., & Balthasar, J. P. (<strong>2009</strong>). Development<strong>and</strong> valid<strong>at</strong>ion <strong>of</strong> an enzyme linked immunosobent assay forthe quantific<strong>at</strong>ion <strong>of</strong> carcinoembryonic antigen in mouseplasma. J Immunoassay Immunochem, 30(4), 418-427.Balu-Iyer, S<strong>at</strong>hy V.Kosloski, M., Miclea, R. D., & Balu-Iyer, S. V. (<strong>2010</strong>). Role <strong>of</strong> Glycosyl<strong>at</strong>ionin Conform<strong>at</strong>ional stability, activity, macromolecularinteraction <strong>and</strong> immunogenicity <strong>of</strong> recombinant human FactorVIII. AAPS Journal, 11 <strong>2009</strong>(3), 424-31.Themistou, E., Singh, I., Shang, C., Balu-Iyer, S. V., Alex<strong>and</strong>ridis,P., & Neelamegham, S. (<strong>2010</strong>). Applic<strong>at</strong>ion <strong>of</strong> fluorescencespectroscopy to quantify shear-induced protein conform<strong>at</strong>ionchange. Biophysical Journal, 97(9), 2567-76.Simpson-Abelson, M. R., Purohit, V. S., Pang, W. M., Iyer, V.,Odunsi, K., Demmy, T. L., Yakota, S. J., Loyall, J. L., Kelleher, R.J., Balu-Iyer, S. V., & Bankert, R. B. (in press). IL-12 DeliveredIntr<strong>at</strong>umorally by Multilamellar Liposomes Reactiv<strong>at</strong>es MemoryT Cells in Human Tumor Microenvironments. Clinical Immunology,132 <strong>2009</strong>(1), 71-82.Balu-Iyer, S. V., Pisal, D. S., & Kosloski, M. (<strong>2010</strong>). Delivery <strong>of</strong>Therapeutic Proteins. Journal <strong>of</strong> Pharmaceutical Sciences, 99<strong>2010</strong>(6), 2557-75.Peng, A., Gaitonde, P., Kosloski, M. P., Miclea, R. D., Varma,P., & Balu-Iyer, S. V. (<strong>2010</strong>). Effect <strong>of</strong> route <strong>of</strong> administr<strong>at</strong>ion<strong>of</strong> human recombinant Factor VIII on its immunogenicity inHemophilia A mice. Journal <strong>of</strong> Pharmaceutical Sciences, 98<strong>2009</strong>(4), 4480-84.Rao, G., Iyer, V., Kosloski, M. P., Pisal, D. S., Midduagh, C. R.,& Balu-Iyer, S. V. (<strong>2010</strong>). Use <strong>of</strong> a folding model <strong>and</strong> in situbiophysical techniques r<strong>at</strong>ional formul<strong>at</strong>ion development <strong>and</strong>stability testing <strong>of</strong> monoclonal antibody therapeutics. Journal<strong>of</strong> Pharmaceutical Sciences, 99 <strong>2010</strong>(4), 1697-706.Peng, A., Straubinger, R. M., & Balu-Iyer, S. V.. Phosph<strong>at</strong>idylinositolcontaining lipidic particle reduces inhibitor development<strong>and</strong> c<strong>at</strong>abolism <strong>of</strong> factor VIII in hemophilia A mice. AAPS J,<strong>2010</strong>; 12:473-81.Blanco, JavierCao, J., Gonzalez-Covarrubias, V., Straubinger, R. M., Wang,H., Duan, X., Yu, H., Qu, J., & Blanco, J. G. (<strong>2010</strong>). A rapid,reproducible, on-the-fly orthogonal array optimiz<strong>at</strong>ionmethod for targeted protein quantific<strong>at</strong>ion by LC/MS <strong>and</strong>its applic<strong>at</strong>ion for accur<strong>at</strong>e <strong>and</strong> sensitive quantific<strong>at</strong>ion <strong>of</strong>carbonyl reductases in human liver. Analyt. Chem., 82(7),2680-9.Zhang, J., & Blanco, J. G. (<strong>2009</strong>). Identific<strong>at</strong>ion <strong>of</strong> the promoter<strong>of</strong> human carbonyl reductase 3 (CBR3) <strong>and</strong> impact <strong>of</strong>common promoter polymorphisms on hep<strong>at</strong>ic CBR3 mRNAexpression. Pharmaceutical Research, 26(9), 2209-15.Choi, J. Y., Barlow, W. E., Hong, C. C., Blanco, J. G., Davis, W.,Rae, J. M., Yeh, I. T., Hutchins, L. F., Livingston, R., Martino,S., Lyss, A. P., Osborne, K., Abel<strong>of</strong>f, M., Hayes, D. F., & Ambrosone,C. B. (<strong>2009</strong>). Nitric oxide synthase (NOS3) variants<strong>and</strong> disease-free survival among tre<strong>at</strong>ed <strong>and</strong> untre<strong>at</strong>edbreast cancer p<strong>at</strong>ients in a SWOG Clinical Trial (S8897). ClinicalCancer Research, 15(16), 5258-66.Cao J., Gonzalez-Covarrubias V., Straubinger R.M., WangH., Duan X., Yu H., Li J., Qu J., <strong>and</strong> Blanco J.G. A Rapid,16


Reproducible, on-the-fly Orthogonal Array Optimiz<strong>at</strong>ionMethod for Targeted Protein Quantific<strong>at</strong>ion by LC/MS <strong>and</strong>its Applic<strong>at</strong>ion for Accur<strong>at</strong>e <strong>and</strong> Sensitive Quantific<strong>at</strong>ion <strong>of</strong>Carbonyl Reductases in Human Liver. Anal Chem. <strong>2010</strong> Apr1;82(7):2680-9.Kuptsova-Clarkson N., Ambrosone C.B., Weiss J., Baer M.R.,Sucheston L.E., Zirpoli G., Kopecky K.J., Ford L., Blanco J.,Wetzler M., <strong>and</strong> Moysich K.B. XPD DNA Nucleotide ExcisionRepair Gene Polymorphisms Associ<strong>at</strong>ed with DNA RepairDeficiency Predict Better Tre<strong>at</strong>ment Outcomes in SecondaryAcute Myeloid Leukemia. Int J Mol Epidemiol Genet. <strong>2010</strong>Aug;1(4):278-294.Brazeau, DanielBrazeau, D. A., & Brazeau, G. A. (<strong>2009</strong>). Role <strong>of</strong> the genomicsrevolution in Pharmaceutics.. Labor<strong>at</strong>ory Medicine, 40, 216-266.C<strong>of</strong>froth, MA., Pol<strong>and</strong>, D., Petrou, E., Brazeau, D., Holmberg,J. <strong>2010</strong>. Environmental symbiont acquisition may not be thesolution to warming seas for reef-building corals. PLoS ONE5(10) e13258.Krishn<strong>at</strong>ry, A. S., Brazeau, D. A., & Fung, H. L. (<strong>2010</strong>). BroadRegul<strong>at</strong>ion <strong>of</strong> M<strong>at</strong>rix <strong>and</strong> Adhesion Molecules in THP-1 HumanMacrophages by Nitroglycerin. Nitric Oxide, 22, 11-17.Renzi, S. E., Brazeau, D. A., Brazeau, G. A., Hess, J., & Adsit,J. A. (<strong>2010</strong>). Student Course Evalu<strong>at</strong>ions with MultipleInstructors. Does Respondent F<strong>at</strong>igue Affect Instructor Evalu<strong>at</strong>ions.American Journal <strong>of</strong> Pharmaceutical Educ<strong>at</strong>ion, 73(4),Article 57, 34.Renzi, S. A., Sauberan, M. M., Brazeau, D. A., & Brazeau, G. A.(<strong>2009</strong>). Rel<strong>at</strong>ionship Between Student Leadership Activities <strong>and</strong>Prepharmacy Years in College. AM J Pharmaceutical Ed, 72(6),Article 149.Fung, Ho LeungKrishn<strong>at</strong>ry, A. S., Brazeau, D. A., & Fung, H. L. (<strong>2010</strong>). BroadRegul<strong>at</strong>ion <strong>of</strong> M<strong>at</strong>rix <strong>and</strong> Adhesion Molecules in THP-1 HumanMacrophages by Nitroglycerin. Nitric Oxide, 22, 11-17.Gao, WenqingGao, W., & Dalton, J. T. (<strong>2009</strong>). Exp<strong>and</strong>ing the therapeutic use <strong>of</strong><strong>and</strong>rogens via selective <strong>and</strong>rogen receptor modul<strong>at</strong>ors (SARMs).Drug Discovery Today, 12(5-6), 241-8.Gao, W., & Dalton, J. T. (<strong>2009</strong>). Ockham’s Razor <strong>and</strong> SelectiveAndrogen Receptor Modul<strong>at</strong>ors (SARMs): Are We Overlookingthe Role <strong>of</strong> 5α-Reductase?. Molecular Intervention, 7(1), 10-13.Pan, Y., Gao, W., & Yu, A. (<strong>2009</strong>). MicroRNAs regul<strong>at</strong>e CYP3A4expression via direct <strong>and</strong> indirect targeting. Drug Metab Dispos,37(10), 2112-2117.Kennedy, B. A., Gao, W., Huang, T., & Jin, V. X. (<strong>2009</strong>). HRTBLDb:an inform<strong>at</strong>ive d<strong>at</strong>a resource for Hormone Receptors TargetBinding Loci. Nucleic Acids Research, 10(38), D676-D681.Gao, W. Peptide Antagonist <strong>of</strong> the Androgen Receptor. CurrPharm Design, 16(9), 1106-1113.Jusko, WilliamWiczling, P., Rosenzweig, M., Vaickus, L., & Jusko, W. J. (<strong>2010</strong>).Pharmacokinetics <strong>and</strong> Pharmacodynamics <strong>of</strong> a Chimeric/Humanized Anti-CD3 Monoclonal Antibody, Otelixizumab(TRX4), in Subjects with Psoriasis <strong>and</strong> with Type 1 DiabetesMellitus. Journal <strong>of</strong> Clinical Pharmacology, 50, 494-506.Bulitta, J. B., Yang, J. C., Yohonn, L., Ly, N. S., Brown, S. V.,D’Hondt, R. E., Jusko, W. J., Forrest, A., & Tsuji, B. T. (<strong>2010</strong>). Attenu<strong>at</strong>ion<strong>of</strong> Colistin Bactericidal Activity by High Incoulum <strong>of</strong>Pseudomonas Aeruginosa Characterized by a New Mechanism-Based Popul<strong>at</strong>ion Pharmacodynamic Model. AntimicrobialAgents <strong>and</strong> Chemotherapy, 54, 2051-2062.Freisht<strong>at</strong>, R. J., Nagaraju, K., Jusko, W. J., & H<strong>of</strong>fman, E. P. (<strong>2010</strong>).Glucocorticoid Efficacy in Asthma: Is Improved Tissue RemodelingUpstream <strong>of</strong> Anti-Inflamm<strong>at</strong>ion. Journal <strong>of</strong> Investig<strong>at</strong>iveMedicine, 58, 19-22.Khinkis, L. A., Krzyzanski, W., Jusko, W. J., & Greco, W. R. (<strong>2009</strong>).D-Optimal Designs for Parameter Estim<strong>at</strong>ion for Indirect PharmacodynamicResponse Models. J Pharmacokinet Pharmacodyn,36, 523-529.17


Bulitta, J. B., Zhao, P., Arnold, R. D., Kessler, D. R., Daifuku, R.,Pr<strong>at</strong>t, J., Luciano, G., Hanauske, A.-R., Gelderblom, H., Awada,A., & Jusko, W. J. (<strong>2009</strong>). Mechanistic Popul<strong>at</strong>ion Pharmacokinetics<strong>of</strong> Total <strong>and</strong> Unbound Paclitaxel for a New NanodropletFormul<strong>at</strong>ion vs. Taxol in Cancer P<strong>at</strong>ients. Cancer ChemotherPharmacol, 63, 1049-1063.Woo, S., Pawaskar, D., & Jusko, W. J. (<strong>2009</strong>). Methods <strong>of</strong>Utilizing Baseline Values for Indirect Response Models. JPharmacokinet Pharmacodyn, 36, 381-405.Bulitta, J. B., Zhao, P., Arnold, R. D., Kessler, D. R., Daifuku, R.,Pr<strong>at</strong>t, J., Luciano, G., Hanauske, A.-R., Gelderblom, H., Awada,A., & Jusko, W. J. (<strong>2009</strong>). Multiple-Pool Lifespan Models forNeutropenia to Assess the Popul<strong>at</strong>ion Pharmacodynamics <strong>of</strong>Unbound Paclitaxel from Two Formul<strong>at</strong>ions in Cancer P<strong>at</strong>ients.Cancer Chemother Pharmacol, 63, 1035-1048.Yang, E. H., Almon, R. R., Dubois, D. C., Jusko, W. J., &Androulakis, I. P. (<strong>2009</strong>). Identific<strong>at</strong>ion <strong>of</strong> Global TranscriptionalDynamics. PLoS ONE, 4(7), e5992.Cho, H.-Y., Blum, R. A., Sunderl<strong>and</strong>, T., Cooper, G. J. S., & Jusko,W. J. (<strong>2009</strong>). Pharmacokinetic <strong>and</strong> Pharmacodynamic Modeling<strong>of</strong> a Copper-Selective Chel<strong>at</strong>or (TETA) in Healthy Adults. TheJournal <strong>of</strong> Clinical Pharmacology, 49, 916-928.Krzyzanski, WojciechWiczling, P., Lowe, P., Pigeolet, E., Ludicke, F., Balser, S., & Krzyzanski,W. (<strong>2009</strong>). Popul<strong>at</strong>ion pharmacokinetic modelling <strong>of</strong> filgrastimin healthy adults following intravenous <strong>and</strong> subcutaneousadministr<strong>at</strong>ions. Clinical Pharamcokinetics, 48(12), 817-826.Khinkis, L. A., Krzyzanski, W., Jusko, W. J., & Greco, W. R.(<strong>2009</strong>). D-Optimal Designs for Parameter Estim<strong>at</strong>ion forIndirect Pharmacodynamic Response Models. J PharmacokinetPharmacodyn, 36, 523-529.Perez-Ruixo, J. J., Krzyzanski, W., Bouman-Thio, E., Miller, B.,Jang, H., Bai, S. A., Zhou, H., Yohrling, J., Cohen, A., Burggraaf,J., Franson, K., & Davis, H. (<strong>2009</strong>). In (Ed.), Pharmacokinetics<strong>and</strong> pharmacodynamics <strong>of</strong> the erythropoietin mimetibodyconstruct CNTO 528 in healthy subjects. Clin. Pharmacokinet.(vol. 48, pp. 601-613).Mager, DonaldKagan, L., Abraham, A. K., Harrold, J. M., & Mager, D. E. (<strong>2010</strong>).Interspecies scaling <strong>of</strong> receptor-medi<strong>at</strong>ed pharmacokinetics <strong>and</strong>pharmacodynamics <strong>of</strong> type I interferons. Pharm Res, 27, 920-932.Abraham, A. K., Kagan, L., Kumar, S., & Mager, D. E. (<strong>2010</strong>).Type I Interferon Receptor is a Primary Regul<strong>at</strong>or <strong>of</strong> Targetmedi<strong>at</strong>edDrug Disposition <strong>of</strong> Interferon-{beta} in Mice.J Pharmacol Exp Ther, 334(1), 327-32.Siluk, D., Mager, D. E., Kim, H. S., Wang, Y., Furimsky, A. M.,Ta, A., Iyer, L. V., Green, C. E., & Wainer, I. W. (<strong>2010</strong>). Pharmacokinetics<strong>and</strong> metabolism <strong>of</strong> (R,R)-methoxyfenoterol in r<strong>at</strong>.Xenobiotica, 40, 195-206.Dhindsa, S., Miller, M. G., McWhirter, C. L., Mager, D. E.,Ghanim, H., Chaudhuri, A., & D<strong>and</strong>ona, P. (<strong>2010</strong>). TestosteroneConcentr<strong>at</strong>ions in Diabetic <strong>and</strong> Non-Diabetic Obese Men.Diabetes Care,33(6), 1186-1192.Yang, J., Mager, D. E., & Straubinger, R. M. (<strong>2010</strong>). Comparison<strong>of</strong> two pharmacodynamic transduction models for the analysis<strong>of</strong> tumor therapeutic responses in model systems. AAPSJournal, 12, 1-10.Zhou, R., Mazurchuk, R. V., Tamburlin, J. H., Harold, J. M.,Mager, D. E., & Straubinger, R. M. (<strong>2010</strong>). Differential pharmacodynamiceffects <strong>of</strong> paclitaxel formul<strong>at</strong>ions in an intracranialr<strong>at</strong> brain tumor model. J Pharmacol Exp Ther, 332(2), 479-88.Hilmer, S. N., Mager, D. E., Simonsick, E. M., Ling, S. M., Windham,B. G., Harris, T. B., Shorr, R. I., Bauer, D. C., & Abernethy,D. R. (<strong>2009</strong>). Drug burden index score <strong>and</strong> functional decline inolder people. Am J Med, 122, 1142-1149.Morris, Marilyn E.An, G., & Morris, M. E. (<strong>2009</strong>). Herbal Supplement-basedInteractions. In K. S. Pang, A. D. Rodrigues, & R. Peter (Eds.),Enzym<strong>at</strong>ic- <strong>and</strong> Transporter-Based Drug Drug Interactions:Progress <strong>and</strong> Future Challenges. Springer<strong>2009</strong>.Morris, M. E., & G<strong>and</strong>hi, Y. A.. ABC Transporters in Intestinal<strong>and</strong> Hep<strong>at</strong>ic Efflux. In M. Hu & X. Li (Eds.), Oral Bioavailability:Basic Principles, Advance Concepts <strong>and</strong> Applic<strong>at</strong>ions, Wiley.An, G., Ruszaj, D. M., & Morris, M. E. (<strong>2010</strong>). Interference <strong>of</strong> asulf<strong>at</strong>e conjug<strong>at</strong>e in quantit<strong>at</strong>ive liquid chrom<strong>at</strong>ography/t<strong>and</strong>em mass spectrometry through in-source dissoci<strong>at</strong>ion.Rapid Commun Mass Spectrom, 24(12), 1817-1819.Yang, X., & Morris, M. E. (<strong>2010</strong>). Pharmacokinetics <strong>and</strong> biliaryexcretion <strong>of</strong> mitoxantrone in r<strong>at</strong>s. J Pharm Sci, 99(5), 25o2-2510.Yang, X., G<strong>and</strong>hi, Y. A., & Morris, M. E. (<strong>2010</strong>). Biliary excretionin dogs: Evidence for a molecular weight threshold. Eur J PharmSci., 40(1), 33-7.An, G., & Morris, M. E. (<strong>2010</strong>). Effects <strong>of</strong> single <strong>and</strong> multipleflavonoids on BCRP-medi<strong>at</strong>ed accumul<strong>at</strong>ion, cytotoxicity <strong>and</strong>transport <strong>of</strong> mitoxantrone in vitro. Pharm Res, Apr 6. [Epubahead <strong>of</strong> print].18


Felmlee, M. A., Roiko, S. A., Morse, B. L., & Morris, M. E.(<strong>2010</strong>). Concentr<strong>at</strong>ion-effect rel<strong>at</strong>ionships for the drug <strong>of</strong>abuse γ-hydroxybutric acid. J Pharmacol Exp Ther, Mar 9.[Epub ahead <strong>of</strong> print].An, G., & Morris, M. E. (<strong>2010</strong>). HPLC Analysis <strong>of</strong> Mitoxantronein Mouse Plasma <strong>and</strong> Tissues: Applic<strong>at</strong>ion in a PharmacokineticStudy. Journal <strong>of</strong> Pharmaceutical <strong>and</strong> Biomedical Analysis,51(3), 750-753.Telang, U., Ji, Y., & Morris, M. E. (<strong>2009</strong>). ABC transporters <strong>and</strong>isothiocyan<strong>at</strong>es: Potential for pharmacokinetic diet-drug interactions.Biopharm Drug Disp, 30(7), 335-344.Yang, X., G<strong>and</strong>hi, Y. A., Duignan, D. B., & Morris, M. E. (<strong>2009</strong>).Prediction <strong>of</strong> Biliary Excretion in R<strong>at</strong>s <strong>and</strong> Humans Using. AAPSJournal, Jul 11. [Epub ahead <strong>of</strong> print]G<strong>and</strong>hi, Y. A., & Morris, M. E. (<strong>2009</strong>). Quantit<strong>at</strong>ive structureactivityrel<strong>at</strong>ionships for breast cancer resistance protein(ABCG2). AAPS Journal(July 24). [Epub ahead <strong>of</strong> print].An G <strong>and</strong> Morris ME. Effects <strong>of</strong> the Is<strong>of</strong>lavonoid Biochanin A onthe Transport <strong>of</strong> Mitoxantrone In Vitro <strong>and</strong> In Vivo, BiopharmDrug Dispos, <strong>2010</strong> 31(5-6): 340-350, <strong>2010</strong>.Syed Alwi, SS, Cavell BE, Telang U, Morris ME, Parry BM <strong>and</strong>Packham G. In vivo modul<strong>at</strong>ion <strong>of</strong> 4E-BP1 phosphoryl<strong>at</strong>ion byw<strong>at</strong>ercress: a pilot study. Br J Nutr 104(9):1288-1296, <strong>2010</strong>.Felmlee MA, Wang Q, Cui D, Roiko SA <strong>and</strong> Morris ME. MechanisticToxicokinetic Model for γ-Hydroxybutyric Acid: Inhibition<strong>of</strong> Active Renal Reabsorption as a Potential Therapeutic Str<strong>at</strong>egy.AAPS J 12(3):407-416, <strong>2010</strong>.Qu, JunQu, J., Lesse, A. J., Brauer, A. L., Cao, J., Gill, S. R., & Murphy,T. F. (<strong>2010</strong>). Proteomic expression pr<strong>of</strong>iling <strong>of</strong> Haemophilusinfluenzae grown in pooled human sputum from adults withchronic obstructive pulmonary disease reveal antioxidant <strong>and</strong>stress responses. BMC Microbiology, 10, 162.Duan, X., Weinstock-Guttman, B., Wang, H., Bang, E., Li, J.,Raman<strong>at</strong>han, M., & Qu, J. (<strong>2010</strong>). Ultrasensitive quantific<strong>at</strong>ion <strong>of</strong>serum vitamin D metabolites using selective solid-phase extractioncoupled to micr<strong>of</strong>low liquid chrom<strong>at</strong>ography <strong>and</strong> isotope-dilutionmass spectrometry. Analytical Chemistry, 82(6), 2488-2497.Cao, J., Gonzalez-Covarrubias, V., Straubinger, R. M., Wang, H.,Duan, X., Yu, H., Qu, J., & Blanco, J. G. (<strong>2010</strong>). A rapid, reproducible,on-the-fly orthogonal array optimiz<strong>at</strong>ion method fortargeted protein quantific<strong>at</strong>ion by LC/MS <strong>and</strong> its applic<strong>at</strong>ionfor accur<strong>at</strong>e <strong>and</strong> sensitive quantific<strong>at</strong>ion <strong>of</strong> carbonyl reductasesin human liver. Analyt. Chem., 82(7), 2680-9.Lee, M.-H., Koria, P., Qu, J., & Andreadis, S. (<strong>2009</strong>). JNK phosphoryl<strong>at</strong>esβ-c<strong>at</strong>enin <strong>and</strong> regul<strong>at</strong>es adherens junctions. TheFASEB Journal, 23(11), 3874+3883.Vagin, V. V., Wohlschlegel, J., Qu, J., Jonsson, Z., Huang, X.,Chuma, S., Girard, A., Sachidan<strong>and</strong>am, R., & Hannon, G. J. (<strong>2009</strong>).Proteomic analysis <strong>of</strong> murine Piwi proteins reveals a role forarginine methyl<strong>at</strong>ion in specifying interaction withTudor familymembers. GENES & DEVELOPMENT, 23(15), 1749-1762.Raman<strong>at</strong>han, MuraliWeinstock-Guttman, B., Raman<strong>at</strong>han, M., Hashmi, K., Abdelrahman,N., Hojnacki, D., Dwyer, M., Hussein, S., Bergsl<strong>and</strong>, N.,Munschauer, F., & Zivadinov, R. (<strong>2010</strong>). Increased tissue damage<strong>and</strong> lesion volumes in African-Americans with multiple sclerosis.Neurology, 74(7), 538-544.Stosic, M., Ambrus, J., Garg, N., Weinstock-Guttman, B.,Raman<strong>at</strong>han, M., Kalman, B., Minagar, A., Durfee, J., Munschauer,F., Galey, T., Hussein, S., Bakshi, R., & Zivadinov, R.(<strong>2010</strong>). MRI characteristics <strong>of</strong> p<strong>at</strong>ients with antiphospholipidsyndrome <strong>and</strong> multiple sclerosis. Journal Neurology,257(1), 63-71.Duan, X., Weinstock-Guttman, B., Wang, H., Bang, E., Li, J.,Raman<strong>at</strong>han, M., & Qu, J. (<strong>2010</strong>). Ultrasensitive quantific<strong>at</strong>ion<strong>of</strong> serum vitamin D metabolites using selective solid-phaseextraction coupled to micr<strong>of</strong>low liquid chrom<strong>at</strong>ography <strong>and</strong>isotope-dilution mass spectrometry. Analytical Chemistry,82(6), 2488-2497.Zivadinov, R., Weinstock-Guttman, B., Hashmi, K., Abdelrahman,N., Stosic, M., Dwyer, M., Hussein, S., Durfee, J., & Raman<strong>at</strong>han,M. (<strong>2010</strong>). Smoking is associ<strong>at</strong>ed with increased lesion volumes<strong>and</strong> <strong>at</strong>rophy in multiple sclerosis. Neurology, 73(7), 504-10.Journal Article, Academic Journal (Published January (1stQuarter/Winter) <strong>2010</strong>) Zivadinov, R., Weinstock-Guttman, B.,Hashmi, K., Abdelrahman, N., Stosic, M., Dwyer, M., Hussein,S., Durfee, J., & Raman<strong>at</strong>han, M. (<strong>2010</strong>). Smoking is associ<strong>at</strong>edwith increased lesion volumes <strong>and</strong> <strong>at</strong>rophy in multiple sclerosis.Neurology, 73(7), 504-10.Kim, T., Hwang, W., Zhang, A., Sen, S., & Raman<strong>at</strong>han, M.(<strong>2010</strong>). Multi-agent modeling <strong>of</strong> the South Korean Avian influenzaepidemic. Proceedings <strong>of</strong> the Royal Society B. Multi-agentModeling <strong>of</strong> the South Korean Avian Influenza Epidemic, BMCInfectious Diseases, 236 (10).19


Schentag, JeromeMonte, S. V., Schentag, J. J., & Paladino, J. A. (<strong>2010</strong>). Characteriz<strong>at</strong>ion<strong>of</strong> Cardiovascular Outcomes in a Type 2 DiabetesGlucose Supply <strong>and</strong> Insulin Dem<strong>and</strong> Model.. Journal <strong>of</strong>Diabetes Science <strong>and</strong> Technology, 4, 382-390.Monte, S. V., Schentag, J. J., & Paladino, J. A. (<strong>2010</strong>). GlucoseSupply <strong>and</strong> Insulin Dem<strong>and</strong> Dynamics <strong>of</strong> Antidiabetic Agents.Journal <strong>of</strong> Diabetes Science <strong>and</strong> Technology, 4, 365-381.Straubinger, RobertCao, J., Gonzalez-Covarrubias, V., Straubinger, R. M., Wang, H.,Duan, X., Yu, H., Qu, J., & Blanco, J. G. (<strong>2010</strong>). A rapid, reproducible,on-the-fly orthogonal array optimiz<strong>at</strong>ion method fortargeted protein quantific<strong>at</strong>ion by LC/MS <strong>and</strong> its applic<strong>at</strong>ionfor accur<strong>at</strong>e <strong>and</strong> sensitive quantific<strong>at</strong>ion <strong>of</strong> carbonyl reductasesin human liver. Analyt. Chem., 82(7), 2680-9.Yang, J., Mager, D. E., & Straubinger, R. M. (<strong>2010</strong>). Comparison<strong>of</strong> two pharmacodynamic transduction models for the analysis<strong>of</strong> tumor therapeutic responses in model systems. AAPSJournal, 12, 1-10.Yu, AimingShen, H., Wu, C., Jiang, X., & Yu, A. (<strong>2010</strong>). Effects <strong>of</strong> monoamineoxidase inhibitor <strong>and</strong> cytochrome P450 2D6 st<strong>at</strong>uson 5-methoxy-N,N-dimethyltryptamine metabolism <strong>and</strong>pharmacokinetics. Biochem Pharmacol., 80(1), 122-128.Shen, H.-W., & Yu, A. (<strong>2009</strong>). Difference in desipraminemetabolic pr<strong>of</strong>ile in CYP2D6-humanized <strong>and</strong> wild-type mice.Drug Metab Lett, 3(4), 234-241.Pan, Y., Gao, W., & Yu, A. (<strong>2009</strong>). MicroRNAs regul<strong>at</strong>e CYP3A4expression via direct <strong>and</strong> indirect targeting. Drug MetabDispos, 37(10), 2112-2117.Wu, C., Jiang, X.-L., Shen, H., & Yu, A. (<strong>2009</strong>). Effects <strong>of</strong>CYP2D6 St<strong>at</strong>us on Harmaline Metabolism, Pharmacokinetics<strong>and</strong> Pharmacodynamics, <strong>and</strong> a Pharmacogenetics-BasedPharmacokinetic Model. Biochem Pharmacol, 78(6), 617-624.Yu AM. Role <strong>of</strong> microRNAs in the regul<strong>at</strong>ion <strong>of</strong> drug metabolism<strong>and</strong> disposition, Expert Opin Drug Metab Toxicol. 5(12):1513-1528 (<strong>2009</strong>).Zhou, R., Mazurchuk, R. V., Tamburlin, J. H., Harold, J. M.,Mager, D. E., & Straubinger, R. M. (<strong>2010</strong>). Differential pharmacodynamiceffects <strong>of</strong> paclitaxel formul<strong>at</strong>ions in an intracranialr<strong>at</strong> brain tumor model. J Pharmacol Exp Ther, 332(2), 479-88.Peng A, Straubinger RM, Balu-Iyer SV. Phosph<strong>at</strong>idylinositolcontaining lipidic particles reduce immunogenicity <strong>and</strong>c<strong>at</strong>abolism <strong>of</strong> factor VIII in hemophilia A mice. AAPS J.<strong>2010</strong>;12:473-81.20


<strong>Pharmacy</strong> PracticeAlbanese, NicoleMonte, S. V., Slazak, E. M., Albanese, N. P., Adelman, M., Rao,G., & Paladino, J. A. (<strong>2009</strong>). Clinical <strong>and</strong> Economic Impact <strong>of</strong> aDiabetes Clinical <strong>Pharmacy</strong> Service Program in a <strong>University</strong> <strong>and</strong>Primary Care-Based Collabor<strong>at</strong>ion Model. J Am Pharm Assoc,49, 200-208.Brown, JackPrescott, W. A., Doloresco, F., Brown, J., & Paladino, J. A.(<strong>2010</strong>). Cost Effectiveness <strong>of</strong> Respir<strong>at</strong>ory Syncytial VirusProphylaxis: A Critical <strong>and</strong> System<strong>at</strong>ic Review.. Pharmaco-Economics, 28(4), 279-93.Brown, J. (<strong>2010</strong>). Daptomycin Use in P<strong>at</strong>ients with Cancer <strong>and</strong>Neutropenia.. Clinical Advances in Hem<strong>at</strong>ology <strong>and</strong> Oncology,8, 1189-95.Venuto, C., & Brown, J. Altern<strong>at</strong>ive Therapies for Clostridiumdifficile Infections. Pharmacotherapy. Pharmacotherapy,30(12),1266–1278.Zak, E., Markert, E., & Brown, J. (<strong>2009</strong>). New agents for grampositivep<strong>at</strong>hogens. Infectious Disease News, 141, 912-13.Doloresco III, FredDoloresco, F., Fominaya, C., & Vermeulen, L. C. (<strong>2010</strong>). Globalsurvey <strong>of</strong> hospital pharmacy practice.. Intern<strong>at</strong>ional PharmaceuticalFeder<strong>at</strong>ion. Am J Health-Syst Pham, 66, S13-S19.H<strong>of</strong>fman, J. M., Doloresco, F., Vermeulen, L. C., Shah, N. D.,M<strong>at</strong>usiak, L., Hunkler, R. J., & Schumock, G. T. (<strong>2010</strong>). Projectingfuture drug expenditures--<strong>2010</strong>. American Journal <strong>of</strong> Health-System <strong>Pharmacy</strong>, 67(11), 919-28.Prescott, W. A., Doloresco, F., Brown, J., & Paladino, J. A.(<strong>2010</strong>). Cost Effectiveness <strong>of</strong> Respir<strong>at</strong>ory Syncytial VirusProphylaxis: A Critical <strong>and</strong> System<strong>at</strong>ic Review. Pharmaco-Economics, 28(4), 279-93.Morse, E. D., Fiebelkorn, K. D., Ceusters, W., Bessette, R.,Furlani, T., Singh, R., Hayward, A., Notaro, J., C<strong>at</strong>anzaro, C.,Billittier, A., Porreca, D., & Holm, B. A. Developing a Bioinform<strong>at</strong>ics<strong>and</strong> Medic<strong>at</strong>ion Management Research Network.J California Pharm Assoc, 56(3), 58-61.Forrest, AlanBulitta JB, Yang JC, Yohonn L, Ly NS, Brown SV, D’Hondt RE,Jusko WJ, Forrest A, Tsuji BT. Attenu<strong>at</strong>ion <strong>of</strong> colistin bactericidalactivity by high inoculum <strong>of</strong> Pseudomonas aeruginosacharacterized by a new mechanism-based popul<strong>at</strong>ion pharmacodynamicmodel. Antimicrob Agents Chemother. <strong>2010</strong>May;54(5):2051-62. Epub <strong>2010</strong> Mar 8.Moise PA, Forrest A, Bayer AS, Xiong YQ, Yeaman MR, SakoulasG. Factors influencing time to vancomycin-induced clearance<strong>of</strong> nonendocarditis methicillin-resistant Staphylococcus aureusbacteremia: role <strong>of</strong> pl<strong>at</strong>elet microbicidal protein killing <strong>and</strong>agr genotypes. J Infect Dis. <strong>2010</strong> Jan 15;201(2):233-40.Rubino CM, Van Wart SA, Bhavnani SM, Ambrose PG, McCollamJS, Forrest A. Oritavancin popul<strong>at</strong>ion pharmacokineticsin healthy subjects <strong>and</strong> p<strong>at</strong>ients with complic<strong>at</strong>ed skin <strong>and</strong>skin structure infections or bacteremia. Antimicrob AgentsChemother. <strong>2009</strong> Oct;53(10):4422-8. Epub <strong>2009</strong> Jul 27.Harigaya Y, Bulitta JB, Forrest A, Sakoulas G, Lesse AJ, MylotteJM, Tsuji BT. Pharmacodynamics <strong>of</strong> vancomycin <strong>at</strong> simul<strong>at</strong>edepithelial lining fluid concentr<strong>at</strong>ions against methicillinresistantStaphylococcus aureus (MRSA): implic<strong>at</strong>ions fordosing in MRSA pneumonia. Antimicrob Agents Chemother.<strong>2009</strong> Sep;53(9):3894-901. Epub <strong>2009</strong> Jul 13.Havard, P<strong>at</strong>tyLiu, Z., Wu, J., Xie, Z., Havard, P. F., Liu, S., Huang, T. H.,Plassc, C., Marcucci, G., & Chan, K. K. (<strong>2009</strong>). Quantific<strong>at</strong>ion<strong>of</strong> Regional DNA Methyl<strong>at</strong>ion by Liquid Chrom<strong>at</strong>ography/T<strong>and</strong>em Mass Spectrometry. Analytical Biochemistry,391(2), 106-113.Ma, QingChen J, Sun J, Ma Q, Yao Y, Wang Z, Zhang L, Li L, Sun F,Lu H. CYP2B6 polymorphism <strong>and</strong> nonnucleoside reversetranscriptase inhibitor plasma concentr<strong>at</strong>ions in Chinese HIVinfectedp<strong>at</strong>ients. Ther Drug Monit. <strong>2010</strong>;32(5):573-8.Liu X, Ma Q, Zhang F. Therapeutic drug monitoring inhighly active antiretroviral therapy. Expert Opin Drug Saf.<strong>2010</strong>;9(5):743-58.Zhang L, Zhang X, Ma Q, Ma F, Zhou H. Transcriptomics <strong>and</strong>proteomics in the study <strong>of</strong> H1N1 <strong>2009</strong>. Genomics ProteomicsBioinform<strong>at</strong>ics. <strong>2010</strong>;8(3):139-44.21


Bruce RD, Altice FL, Moody DE, Morse GD, Andrews L, Lin SN,Fang WB, Ma Q, Friedl<strong>and</strong> GH. Pharmacokinetic interactionsbetween buprenorphine/naloxone <strong>and</strong> once-daily lopinavir/ritonavir. J Acquir Immune Defic Syndr. <strong>2010</strong>;54(5):511-4.Zhang RF, Sun HQ, Huang Q, Wang JR, Zhang XX, Liu XN,Ma Q, Lu HZ. Efficacy <strong>and</strong> safety <strong>of</strong> pegyl<strong>at</strong>ed interferonalpha-2a therapy for chronic hep<strong>at</strong>itis C in HIV-infectedp<strong>at</strong>ients with haemophilia. Haemophilia. <strong>2010</strong>;16(3):502-7.Epub <strong>2009</strong> Dec 20.Zhang L, Zhang X, Ma Q, Zhou H. Host proteome researchin HIV infection. Genomics Proteomics Bioinform<strong>at</strong>ics.<strong>2010</strong>;8(1):1-9.McCance-K<strong>at</strong>z EF, Moody DE, Morse GD, Ma Q, Rainey PM. Lack<strong>of</strong> clinically significant drug interactions between nevirapine<strong>and</strong> buprenorphine. Am J Addict. <strong>2010</strong>;19: 30-7.Baker J, Rainey PM, Moody DE, Morse GD, Ma Q, McCance-K<strong>at</strong>z EF. Interactions between buprenorphine <strong>and</strong> antiretrovirals:nucleos(t)ide reverse transcriptase inhibitors(NRTI) didanosine, lamivudine, <strong>and</strong> ten<strong>of</strong>ovir. Am J Addict.<strong>2010</strong>;19: 17-29.Lakhman SS, Ma Q, Morse GD. Pharmacogenomics <strong>of</strong> CYP3A:consider<strong>at</strong>ions for HIV tre<strong>at</strong>ment. Pharmacogenomics.<strong>2009</strong>;10:1323-39.Monte, ScottMonte, S. V., Comerford, P., & Dearing, N. (<strong>2010</strong>). An Analysis<strong>of</strong> the Mixing Efficiency <strong>of</strong> Neutral Protamine HagedornCartridges. Journal <strong>of</strong> Diabetes Science <strong>and</strong> Technology,4(<strong>2010</strong>), 658-660.Monte, S. V., Schentag, J. J., & Paladino, J. A. (<strong>2010</strong>). Characteriz<strong>at</strong>ion<strong>of</strong> Cardiovascular Outcomes in a Type 2 Diabetes GlucoseSupply <strong>and</strong> Insulin Dem<strong>and</strong> Model.. Journal <strong>of</strong> DiabetesScience <strong>and</strong> Technology, 4, 382-390.Monte, S. V., Slazak, E. M., Albanese, N. P., Adelman, M., Rao,G., & Paladino, J. A. (<strong>2009</strong>). Clinical <strong>and</strong> Economic Impact <strong>of</strong> aDiabetes Clinical <strong>Pharmacy</strong> Service Program in a <strong>University</strong> <strong>and</strong>Primary Care-Based Collabor<strong>at</strong>ion Model. J Am Pharm Assoc,49, 200-208.Monte, S. V., Schentag, J. J., & Paladino, J. A. (<strong>2010</strong>). GlucoseSupply <strong>and</strong> Insulin Dem<strong>and</strong> Dynamics <strong>of</strong> Antidiabetic Agents.Journal <strong>of</strong> Diabetes Science <strong>and</strong> Technology, 4, 365-381.Morse, GeneDunkle, M. N., Hochreister, J., DiFrancesco, R., Morse, E. D., &Colon, L. A. (<strong>2009</strong>). Separ<strong>at</strong>ion <strong>of</strong> Phosphoryl<strong>at</strong>ed NucleosideReverse Transcriptase Inhibitors by Capillary electrophoresis.Microchemical Journal, 93, 17-21.Lakhman, S. S., Ma, Q., & Morse, E. D. (<strong>2009</strong>). Pharmacogenomics<strong>of</strong> CYP3A: consider<strong>at</strong>ions for HIV tre<strong>at</strong>ment. Pharmacogenomics,10(8), 1323-1339.Baker J, Rainey PM, Moody DE, Morse GD, Ma Q, McCance-K<strong>at</strong>z EF. Interactions between Buprenorphine <strong>and</strong> Antiretrovirals:Nucleos(t)ide Reverse Transcriptase Inhibitors (NRTI)Didanosine, Lamivudine, <strong>and</strong> Ten<strong>of</strong>ovir. Am J Addict. <strong>2010</strong> Jan1;19(1):17-29. PMID: 20132118.McCance-K<strong>at</strong>z EF, Moody DE, Morse GD, Ma Q, Rainey PM. Lack<strong>of</strong> Clinically Significant Drug Interactions between Nevirapine<strong>and</strong> Buprenorphine. Am J Addict. <strong>2010</strong> Jan 1; 19(1):30-7. PMID:20132119.Sax PE, Tierney C, Collier AC, Fischl MA, Mollan K, PeeplesL, Godfrey C, Jahed NC, Myers L, K<strong>at</strong>zenstein D, FarajallahA, Rooney JF, Ha B, Woodward WC, Koletar SL, Johnson VA,Geiseler PJ, Daar ES; AIDS Clinical Trials Group Study A5202Team (Morse GD). Abacavir-lamivudine versus ten<strong>of</strong>oviremtricitabinefor initial HIV-1 therapy. N Engl J Med. <strong>2009</strong>Dec 3;361 (23):2230-40. Epub <strong>2009</strong> Dec 1.Morse, E. D., Fiebelkorn, K. D., Ceusters, W., Bessette, R.,Furlani, T., Singh, R., Hayward, A., Notaro, J., C<strong>at</strong>anzaro, C.,Billittier, A., Porreca, D., & Holm, B. A. Developing a Bioinform<strong>at</strong>ics<strong>and</strong> Medic<strong>at</strong>ion Management Research Network. JCalifornia Pharm Assoc, 56(3), 58-61.Baker J, Rainey PM, Moody DE, Morse GD, Ma Q, McCance-K<strong>at</strong>zEF. Interactions between Buprenorphine <strong>and</strong> Antiretrovirals:Nucleos(t)ide Reverse Transcriptase Inhibitors (NRTI) Didanosine,Lamivudine, <strong>and</strong> Ten<strong>of</strong>ovir. Am J Addict. <strong>2010</strong> Jan 1;19(1):17-29.PMID: 20132118.Norgard, NicholasNorgard, N. B. (<strong>2009</strong>). Cangrelor: a novel P2Y12 receptorantagonist.. Expert Opinion on Investig<strong>at</strong>ional Drugs, 18(8),1219-30.Serebruany, V., Malinin, A., Aradi, D., Norgard, N. B., & Boden,W. The in vitro effects <strong>of</strong> niacin on pl<strong>at</strong>elet biomarkers inhuman volunteers. Thromb <strong>and</strong> Haemost, 104(2), 311-317.22


Norgard, N. B., & Abu-Fadel, M. (<strong>2009</strong>). Comparison <strong>of</strong>prasugrel <strong>and</strong> clopidogrel in p<strong>at</strong>ients with acute coronarysyndrome undergoing percutaneous coronary intervention.Vascular Health <strong>and</strong> Risk Management, <strong>2009</strong>, 873-882.Paladino, JosephMonte, S. V., Schentag, J. J., & Paladino, J. A. (<strong>2010</strong>). Characteriz<strong>at</strong>ion<strong>of</strong> Cardiovascular Outcomes in a Type 2 DiabetesGlucose Supply <strong>and</strong> Insulin Dem<strong>and</strong> Model.. Journal <strong>of</strong>Diabetes Science <strong>and</strong> Technology, 4, 382-390.Prescott, W. A., Doloresco, F., Brown, J., & Paladino, J. A.(<strong>2010</strong>). Cost Effectiveness <strong>of</strong> Respir<strong>at</strong>ory Syncytial VirusProphylaxis: A Critical <strong>and</strong> System<strong>at</strong>ic Review.. Pharmaco-Economics, 28(4), 279-93.Monte, S. V., Slazak, E. M., Albanese, N. P., Adelman, M., Rao,G., & Paladino, J. A. (<strong>2009</strong>). Clinical <strong>and</strong> Economic Impact <strong>of</strong>a Diabetes Clinical <strong>Pharmacy</strong> Service Program in a <strong>University</strong><strong>and</strong> Primary Care-Based Collabor<strong>at</strong>ion Model. J Am PharmAssoc, 49, 200-208.Monte, S. V., Schentag, J. J., & Paladino, J. A. (<strong>2010</strong>). GlucoseSupply <strong>and</strong> Insulin Dem<strong>and</strong> Dynamics <strong>of</strong> Antidiabetic Agents.Journal <strong>of</strong> Diabetes Science <strong>and</strong> Technology, 4, 365-381.Pasko, MaryMao, C. l., Rivet, A. J., Sidora, T., & Pasko, M. T. (<strong>2010</strong>). Upd<strong>at</strong>eon Pressure Ulcer Management <strong>and</strong> Deep Tissue Injury. TheAnnals <strong>of</strong> Pharmacotherapy, 44, 325-332.Prescott, GinaSlazak EM, Zurick GM. A Practice-Based Learning Experienceto Develop Residents as Clinical Faculty Members. Am JHealth-Syst Pharm. <strong>2009</strong>,66:1224-7.Prescott Jr, WilliamPrescott, W. A., Doloresco, F., Brown, J., & Paladino, J. A.(<strong>2010</strong>). Cost Effectiveness <strong>of</strong> Respir<strong>at</strong>ory Syncytial VirusProphylaxis: A Critical <strong>and</strong> System<strong>at</strong>ic Review.. Pharmaco-Economics, 28(4), 279-93.Prescott, W. A. (<strong>2010</strong>). Preparing <strong>Pharmacy</strong> Students for theASHP Midyear Clinical Meeting <strong>and</strong> Post-gradu<strong>at</strong>e TrainingSearch. American Journal <strong>of</strong> Pharmaceutical Educ<strong>at</strong>ion, 74,Article 9.Prescott, W. A., & Nagel, J. L. (<strong>2010</strong>). Extended-IntervalOnce-Daily Dosing <strong>of</strong> Aminoglycosides in Adult <strong>and</strong> Pedi<strong>at</strong>ricP<strong>at</strong>ients with Cystic Fibrosis. Pharmacotherapy, 30(1), 95-108.Brazeau, G. A., Meyer, S., Belsey, M., Bednarczyk, E. M., Bilic,S., Bullock, J., DeL<strong>and</strong>er, G., Fiese, E. F., Giroux, S. L., McN<strong>at</strong>ty,D., Nemire, R., Prescott, W. A., & Traynor, A. P. (<strong>2009</strong>). Preparing<strong>Pharmacy</strong> Gradu<strong>at</strong>es for Traditional <strong>and</strong> Emerging CareerOpportunities. American Journal <strong>of</strong> <strong>Pharmacy</strong> Educ<strong>at</strong>ion, 73,Article 157.Slazak, ErinMonte, S. V., Slazak, E. M., Albanese, N. P., Adelman, M., Rao,G., & Paladino, J. A. (<strong>2009</strong>). Clinical <strong>and</strong> Economic Impact <strong>of</strong>a Diabetes Clinical <strong>Pharmacy</strong> Service Program in a <strong>University</strong><strong>and</strong> Primary Care-Based Collabor<strong>at</strong>ion Model. J Am PharmAssoc, 49, 200-208.Slazak EM, Zurick GM. A Practice-Based Learning Experienceto Develop Residents as Clinical Faculty Members. Am JHealth-Syst Pharm. <strong>2009</strong>,66:1224-7.Torn<strong>at</strong>ore-Morse, K<strong>at</strong>hleenNaunani, N., Singh, N., Shanahan, T., Damodar, A., Parisoo,N., Ummadi, S., Qazi, Y., Murray, B., Torn<strong>at</strong>ore-Morse, K. M.,Ciccirella, J., Blessios, G., & Venuto, R. (<strong>2010</strong>). Cross ReactiveEpitope Group antibodies in sensitized kidneys transplantrecipients was associ<strong>at</strong>ed with early acute Antibody Medi<strong>at</strong>edRejection. Transplant Immunology, 20, 113-117.Damodar, A., Mustafa, R., Bh<strong>at</strong>nagar, J., Panesar, M.,Gundroo, A., Zachariah, M., Blessios, G., Torn<strong>at</strong>ore-Morse, K.M., Weber-Shrikant, E., & Venuto, R. (<strong>2010</strong>). Use <strong>of</strong> Anti-CD20Antibody in the tre<strong>at</strong>ment <strong>of</strong> Post-Transplant Glomerulonephritis..Clinical Transplant<strong>at</strong>ion, 10, 1399-1412.Nainani N, Singh N, Shanahan T, Damodar A, Parimoo N,Ummadi S, Qazi Y, Murray BM, Torn<strong>at</strong>ore KM, CiccirellaJC, Blessios GA, Venuto RC. Cross Reactive Epitope GroupAntibodies in Sensitized Kidneys Transplant recipients wasassoci<strong>at</strong>ed with Early Acute Antibody Medi<strong>at</strong>ed Rejection.Transplant Immunology, 20, 113-117.Zachariah, M Torn<strong>at</strong>ore, KM; Venuto RC ; Kidney Transplant<strong>at</strong>ion<strong>and</strong> pregnancy. Current Opinion in Organ Transplant<strong>at</strong>ion,14, 386-391.23


Tsuji, BrianBulitta, J. B., Yang, J. C., Yohonn, L., Ly, N. S., Brown, S. V.,D’Hondt, R. E., Jusko, W. J., Forrest, A., & Tsuji, B. T. (<strong>2010</strong>).Attenu<strong>at</strong>ion <strong>of</strong> Colistin Bactericidal Activity by High Incoulum<strong>of</strong> Pseudomonas Aeruginosa Characterized by a NewMechanism-Based Popul<strong>at</strong>ion Pharmacodynamic Model.Antimicrobial Agents <strong>and</strong> Chemotherapy, 54, 2051-2062.Wrobel, MarkAlbanese, N. P., & Wrobel, M. J. Systemic Lupus Erythem<strong>at</strong>osus.In Pharmacotherapy Casebook: A P<strong>at</strong>ient-Focused Approach(8th ed.). New York, NY: McGraw-Hill.Office <strong>of</strong> the DeanHess, JenniferRenzi, S. E., Brazeau, D. A., Brazeau, G. A., Hess, J., & Adsit, J.A. (<strong>2010</strong>). Student Course Evalu<strong>at</strong>ions with Multiple Instructors.Does Respondent F<strong>at</strong>igue Affect Instructor Evalu<strong>at</strong>ions. AmericanJournal <strong>of</strong> Pharmaceutical Educ<strong>at</strong>ion, 73(4), Article 57, 34.Triggle, DavidTriggle, D. J. (<strong>2010</strong>). Pharmaceuticals in Society. In K. Kummerer(Ed.), Green <strong>and</strong> Sustainable <strong>Pharmacy</strong>. Berlin: Springer.Kapoor Hall Groundbreaking24


Special Honors for Faculty <strong>and</strong> StaffEdward Bednarczyk, clinical associ<strong>at</strong>e pr<strong>of</strong>essor, appointedas Chair-elect (<strong>2010</strong>-2011) <strong>of</strong> the Clinical Sciences section <strong>of</strong> theAPhA-Academy <strong>of</strong> the Pharmaceutical Research <strong>and</strong> Science.Daniel Brazeau, research associ<strong>at</strong>e pr<strong>of</strong>essor, recipient <strong>of</strong> the<strong>2010</strong> <strong>University</strong> <strong>at</strong> <strong>Buffalo</strong> Teaching Innov<strong>at</strong>ion Award recipient.Gayle Brazeau promoted to Full Pr<strong>of</strong>essor.Peter Brody, clinical assistantpr<strong>of</strong>essor, recipient <strong>of</strong> the <strong>2010</strong> SoPPSTeacher <strong>of</strong> the Year Award.Alice Ceacareanu, assistant pr<strong>of</strong>essor,appointed to the board <strong>of</strong> directors<strong>of</strong> the New York St<strong>at</strong>e Council <strong>of</strong>Health-System Pharmacists Research<strong>and</strong> Educ<strong>at</strong>ion Found<strong>at</strong>ion <strong>and</strong>was awarded the Clinical <strong>Pharmacy</strong>Services Research Award by theNew York St<strong>at</strong>e Council <strong>of</strong> Health-System Pharmacists.Peter BrodyElizabeth Rugg, Sara Renzi, Jill HochreiterAlan Forrest, research pr<strong>of</strong>essor,recipient <strong>of</strong> the Oncology One Award from the AmericanSociety <strong>of</strong> Clinical Oncology.Jill Hochreiter, senior research support specialist, finalist,<strong>2010</strong> SoPPS Staff Member <strong>of</strong> the Year Award.Donald Mager, associ<strong>at</strong>e pr<strong>of</strong>essor, elected as a Fellow in theAmerican College <strong>of</strong> Clinical Pharmacology <strong>and</strong> elected as ViceChair, American Associ<strong>at</strong>ion <strong>of</strong> Pharmaceutical Sciences, ClinicalPharmacology <strong>and</strong> Transl<strong>at</strong>ional Research.Marilyn Morris, pr<strong>of</strong>essor, elected Member-At-Large,American Associ<strong>at</strong>ion <strong>of</strong> Pharmaceutical Sciences <strong>and</strong> wasthe recipient <strong>of</strong> the Faculty Service Award, SoPPS <strong>Pharmacy</strong>Leadership Society, Beta Omicron Chapter.Gene Morse, pr<strong>of</strong>essor, appointed as Co-chair Oral HIV/AIDS Research Alliance, Oral Pharmacokinetics Focus Group<strong>and</strong> to the steering committee <strong>of</strong> the New York St<strong>at</strong>eResearch Centers Consortium Dr. Morse was also appointedas the Associ<strong>at</strong>e Director <strong>of</strong> the New York St<strong>at</strong>e Center <strong>of</strong>Excellence in Bioinform<strong>at</strong>ics <strong>and</strong> Life Sciences.Nicholas Norgard, clinical assistant pr<strong>of</strong>essor, finalist,<strong>2010</strong> SoPPS Teacher <strong>of</strong> the Year Award.Joseph Paladino, clinical pr<strong>of</strong>essor, elected to the Board <strong>of</strong>Directors <strong>of</strong> the Society <strong>of</strong> Infectious Disease Pharmacists.Mary Pasko, clinical associ<strong>at</strong>e pr<strong>of</strong>essor, recipient <strong>of</strong> the <strong>2010</strong>SoPPS <strong>Pharmacy</strong> Practice Preceptor <strong>of</strong> the Year Award.Murali Raman<strong>at</strong>han, associ<strong>at</strong>e pr<strong>of</strong>essor, finalist, <strong>2010</strong> SoPPSTeacher <strong>of</strong> the Year Award.Alfred Reiman, clinical assistant pr<strong>of</strong>essor, recipient <strong>of</strong> theIndividual <strong>School</strong> Spirit Award <strong>at</strong> the <strong>2009</strong> American Associ<strong>at</strong>ion<strong>of</strong> Colleges <strong>of</strong> <strong>Pharmacy</strong> Annual Meeting.Sara Renzi, administr<strong>at</strong>ive assistant, finalist, <strong>2010</strong> SoPPS StaffMember <strong>of</strong> the Year Award.Elizabeth Rugg, senior staff assistant, recipient, <strong>2010</strong> SoPPSStaff Member <strong>of</strong> the Year AwardJerome Schentag, pr<strong>of</strong>essor, recipient <strong>of</strong> the <strong>2010</strong> <strong>University</strong><strong>at</strong> <strong>Buffalo</strong> Faculty Entrepreneur Award.Christine Stumm promoted to the Assistant Director <strong>of</strong>Admissions <strong>and</strong> also appointed Co-chair <strong>of</strong> the NewsletterCommittee <strong>and</strong> Executive Board Member <strong>of</strong> the New YorkAssoci<strong>at</strong>ion for College Admission Counseling.Brian Tsuji, assistant pr<strong>of</strong>essor, recipient <strong>of</strong> the Pfizer <strong>2009</strong>ASPIRE Young Investig<strong>at</strong>or Award in Antibacterial Research.Robert Wahler, clinical assistant pr<strong>of</strong>essor, appointed sectionleader <strong>of</strong> the N<strong>at</strong>ional Council <strong>of</strong> Hospice <strong>and</strong> Palli<strong>at</strong>iveCare Pr<strong>of</strong>essionals.25


Thanks to you...Construction on Kapoor Hallcre<strong>at</strong>es sense <strong>of</strong> communityfor students, faculty, staff <strong>and</strong> alumniAs John <strong>and</strong> Editha Kapoor Hall takes shape on the South Campus,donors have responded enthusiastically to the promise it <strong>of</strong>fersstudents, faculty <strong>and</strong> staff. Construction on the school’s new home isprogressing quickly. The structure is now encased by a glass wall <strong>and</strong>the interior framework is evolving into the lecture halls, classrooms,labs, p<strong>at</strong>ient assessment suites <strong>and</strong> other spaces th<strong>at</strong> faculty <strong>and</strong> staffwill occupy in 2012.Donors, inspired by the potential th<strong>at</strong> Kapoor Hall <strong>of</strong>fers the school,have committed generous support to name spaces within the building.These spaces provide donor legacies while inspiring students, wholearn about alumni <strong>and</strong> friends who have made significant contributionsth<strong>at</strong> have shaped the pr<strong>of</strong>ession.Following the lead <strong>of</strong> John N. Kapoor, who has given $10.8 million to thepharmacy school, several alumni <strong>and</strong> friends have added their support:• Members <strong>of</strong> the Panasci Family—Faye Panasci, whose l<strong>at</strong>e husb<strong>and</strong><strong>and</strong> f<strong>at</strong>her-in-law, Henry A. Panasci Jr. <strong>and</strong> Henry A. Panasci Sr.,were UB pharmacy gradu<strong>at</strong>es; her son David A. Panasci; <strong>and</strong>daughter, Beth Leventhal—are funding the building’s <strong>at</strong>rium.• Ron Isaacs ’56 made a significant don<strong>at</strong>ion, which will fund theRonald J. Isaacs Lecture Hall.• Alfonse Muto ’83, president <strong>of</strong> Pine <strong>Pharmacy</strong> <strong>and</strong> Home CareCenter in Williamsville, New York, will fund the <strong>Pharmacy</strong> CareLearning Center classroom, which will be named after his business.• CVS Caremark is funding a student organiz<strong>at</strong>ion suite.Other donors funded p<strong>at</strong>ient assessment <strong>and</strong> counseling rooms:• Ralph Behling ’40• Bruce ’57 <strong>and</strong> Barbara Moden• Stephen ’81 <strong>and</strong> Carolyn Giroux • Salvi Parpia ’88• Margaret Hempling McGlynn ’82 • Tom ’84 <strong>and</strong> Rachel Spire Smith ’84• Robert ’59 <strong>and</strong> Sharon Miller • Ken Yee ’75To read more about these donors <strong>and</strong> their gifts, visit the Givingsection <strong>of</strong> the school’s website: http://pharmacy.buffalo.edu.Designed with open spaces <strong>and</strong> an abundance <strong>of</strong> n<strong>at</strong>ural light, KapoorHall will cre<strong>at</strong>e a sense <strong>of</strong> community for students, faculty, staff <strong>and</strong>alumni. It is an example <strong>of</strong> practicing sustainable architecture in itsreuse <strong>and</strong> renov<strong>at</strong>ion <strong>of</strong> an existing building, the former AchesonHall. The 147,000-square-foot structure is targeting silver certific<strong>at</strong>ionfrom Leadership in Energy <strong>and</strong> Environmental Design (LEED), agreen building n<strong>at</strong>ional r<strong>at</strong>ing system th<strong>at</strong> provides st<strong>and</strong>ards forenvironmentally sustainable construction.Jan ’59 <strong>and</strong> Rose Mary (Crimaldi) Madejski ‘59Margaret (Crimaldi) Quinn ’60During fiscal year <strong>2009</strong>-10, the pharmacy school again rankedsecond among all UB schools in terms <strong>of</strong> alumni particip<strong>at</strong>ion.The school increased the total number <strong>of</strong> dollars raised by28 percent, with collections totaling $3,549,030. Additionally,the school received gifts from 82 new donors <strong>and</strong> 123 donorsfrom the previous fiscal year increased the amount they gavethis year. The school also welcomed seven new members tothe Willis G. Gregory Society, for a total <strong>of</strong> 75 members.26


‘Coal Miner’s Daughters’ ContinueTradition <strong>of</strong> GivingRose Mary Madejski <strong>and</strong> her sister, the Hon. Margaret J.Crimaldi Quinn, know firsth<strong>and</strong> the value <strong>of</strong> scholarships:as high school students—<strong>and</strong> self-described ‘coal miner’sdaughters’— the Crimaldi girls were thriving academically butstruggling financially.Their practical solution was to <strong>at</strong>tend secretarial school aftergradu<strong>at</strong>ion, but a guidance counselor intervened on their behalf.Recognizing their abilities, she arranged for scholarships th<strong>at</strong>allowed them to <strong>at</strong>tend UB.Rose Mary found another mentor <strong>at</strong> UB: Asa Bertram Lemon,then dean <strong>of</strong> the pharmacy school, who told her “You just takecare <strong>of</strong> the grades, <strong>and</strong> I’ll take care <strong>of</strong> the scholarships.” In 1959,she earned a B.S. from the school, where she became a clinicalassistant pr<strong>of</strong>essor.Over the course <strong>of</strong> her career, Rose Mary <strong>and</strong> her husb<strong>and</strong>, Jan,owned a community pharmacy which specialized in consultantpharmacy services; she also practiced as a hospital <strong>and</strong> communitypharmacist <strong>and</strong> currently works for Rite Aid. Margaret earned a B.S.from the pharmacy school in 1960, worked as a pharmacist, thenreturned to UB as a law student, gradu<strong>at</strong>ing in 1970. Throughouttheir careers, the sisters have remained generous donors to UB <strong>and</strong>their respective schools.Margaret, a retired administr<strong>at</strong>ive law judge for the Social SecurityAdministr<strong>at</strong>ion, established the Margaret Crimaldi Quinn Scholarshipfor law students with financial need. “I would not have gradu<strong>at</strong>edif it had not been for scholarships,” she said then. “When youreceive, you have to learn to give back. Otherwise people in similarcircumstances will not make it.”Rose Mary <strong>and</strong> Jan Madejski established the Crimaldi-MadejskiFamily Scholarship in the pharmacy school, to which Rose Mary, Jan,Margaret <strong>and</strong> the Madejski children also make annual don<strong>at</strong>ions.The fund has supported six deserving pharmacy students, mostrecently Amy L. Wojciechowski, a 2012 PharmD c<strong>and</strong>id<strong>at</strong>e.Amy has worked as an intern in the pharmacy <strong>of</strong> Niagara FallsMemorial Medical Center for the past several years <strong>and</strong> said th<strong>at</strong>the experience “has confirmed th<strong>at</strong> I want to pursue a career inhospital pharmacy.”“I enjoy the excitement <strong>of</strong> helping guide decisions regardingp<strong>at</strong>ients’ medical therapy <strong>and</strong> seeing the positive results th<strong>at</strong> comefrom these interventions,” she said. “It is quite fulfilling to w<strong>at</strong>chp<strong>at</strong>ients progress during their hospital stay, knowing the positiveimpact I have had in improving their medical condition in thehospital <strong>and</strong> their quality <strong>of</strong> life after they are discharged.”Amy said she was honored to be chosen as a recipient <strong>of</strong> the Crimaldi-Madejski scholarship, which she said “has given me the freedom t<strong>of</strong>ocus on my educ<strong>at</strong>ion <strong>and</strong> to spend time developing the skills th<strong>at</strong>will be crucial in my future pr<strong>of</strong>ession.”The sisters claim th<strong>at</strong> they are the ones who have received muchmore from giving to UB, including meeting <strong>and</strong> following thecareers <strong>of</strong> the students who benefit from their generosity. Inspired?Please contact the pharmacy development <strong>of</strong>fice <strong>at</strong> 645-3432 todiscuss how you can make a difference through don<strong>at</strong>ing to UB.“RECEIVING THE CRIMALDI-MADEJSKI SCHOLARSHIP has givenme the freedom to focus on my educ<strong>at</strong>ion <strong>and</strong> to spend timedeveloping the skills th<strong>at</strong> will be crucial in my future pr<strong>of</strong>ession.”Amy Wojciechowski, Class <strong>of</strong> 201227


DONOR HONOR ROLLClass <strong>of</strong> 1937Loyalty ClubIrwin BrockClass <strong>of</strong> 1938Loyalty ClubBe<strong>at</strong>rice NobleClass <strong>of</strong> 1939Mortar <strong>and</strong> Pestle ClubJames JohnsonLoyalty ClubHarold MillarClass <strong>of</strong> 1943Loyalty ClubRobert YeagerClass <strong>of</strong> 1947Century ClubMarvin KorusLoyalty ClubDonald PeeblesClass <strong>of</strong> 1949Loyalty ClubSigmund CarsellClass <strong>of</strong> 1950Mortar <strong>and</strong> Pestle ClubSylvia GiordanoClass <strong>of</strong> 19511886 ClubFlorence McMahonLoyalty ClubJohn Hackney Jr.K<strong>at</strong>hleen MonachinoPhilip RuslinkClass <strong>of</strong> 1952Willis G. Gregory SocietyMilner ForsterGerald HooleyJoseph StermanMortar <strong>and</strong> Pestle ClubPeter ShakarjianCentury ClubPamela Maude EmersonLoyalty ClubMarian BarnesVincent SaeliWalter StantonClass <strong>of</strong> 1953Willis G. Gregory SocietyJames BuckleyHarold ErtmanAlton TowerMortar <strong>and</strong> Pestle ClubM. Donald PritchardCentury ClubJoseph MroczynskiJohn OakesLoyalty ClubDavid FakeMelville Follett Jr.Frank MessoreNancy SchroederClass <strong>of</strong> 1954Loyalty ClubJoseph BuckleyClass <strong>of</strong> 1955Century ClubCarol BarrIrving SultzLoyalty ClubBernhard WeinsteinClass <strong>of</strong> 1956Willis G. Gregory SocietySpencer BickelJoseph ChazanRonald IsaacsLoyalty ClubAnne AllenLouis BienHerbert FechterJerry RossFrances ScheerClass <strong>of</strong> 1957Willis G. Gregory SocietyBruce ModenCentury ClubHarry ShiftonRobert RavinLoyalty ClubHarold HonigJohn KrawiecJohn McFarl<strong>and</strong>Class <strong>of</strong> 1958Century ClubRichard Polak<strong>of</strong>fMarlene Kieta SchmittLoyalty ClubArdwin BlockGeorge Ciancio Sr.Mary Ann Janiga KrawiecNelson KorusKenneth KushnerJack MayClass <strong>of</strong> 1959Willis G. Gregory SocietyJan MadejskiRose Mary MadejskiRobert MillerPaul MykaMark RosenfeldJoseph Voelkl1886 ClubRosalie GoldsteinCentury ClubJoel GoodrichLeonard Rosok<strong>of</strong>fLoyalty ClubMarshall CohenDavid HammondJoan HectorJoseph RogowskiGary TregerClass <strong>of</strong> 1960Willis G. Gregory SocietyMargaret QuinnCentury ClubMurray NotebaertMichael SalottiLoyalty ClubGertrude CorioRichard CoryClass <strong>of</strong> 1961Willis G. Gregory SocietyBernhard Esch1886 ClubJoseph Rutowski Sr.Mortar <strong>and</strong> Pestle ClubWilliam SchackCentury ClubVitauts AlksLoyalty ClubKenneth GerberSymond JacobsonJanice McGuiganJerome RobinsClass <strong>of</strong> 1962Willis G. Gregory SocietyHe<strong>at</strong>her AckleyWilliam AckleyCentury ClubJohn WhiteheadLoyalty ClubStephen BroadmanClass <strong>of</strong> 1963Loyalty ClubRobert GiaquintoRichard ReuningClass <strong>of</strong> 1964Century ClubVitauts AlksWilliam ErdmanVijay JainLoyalty ClubIra SchneiderClass <strong>of</strong> 1965Willis G. Gregory SocietyAllen BarnettWilliam JuskoCentury ClubLeo GrossmanChester HejnaNorrine McMillanKaren PompiLoyalty ClubWayne ConradRobert HammondClass <strong>of</strong> 1966Mortar <strong>and</strong> Pestle ClubDiane MangusRobert VaccaCentury ClubLinda EdelmanAlfred GavazziRaymond NapieralaLinda Wail<strong>and</strong>Loyalty ClubKenneth LackieClass <strong>of</strong> 1967Willis G. Gregory SocietyThomas Quinlan1886 ClubGary MosherMortar <strong>and</strong> Pestle ClubCharles BainbridgeEdward MroszczakCentury ClubDonald GoelzLoyalty ClubReginald AmeeleJudith KocherLawrence KocherGerald MulcahyClass <strong>of</strong> 1968Mortar <strong>and</strong> Pestle ClubCarol BainbridgeRonald LambSuresh Mar<strong>at</strong>hePhil MonacelliCentury ClubNancy BapstRichard ErsingLoyalty ClubKenneth GlucJames KowalskiVincent MassaroGail Black ProctorRichard ReuningJoel RossRonald WalnickiClass <strong>of</strong> 1969Willis G. Gregory SocietyRonald EvensMortar <strong>and</strong> Pestle ClubRalph WynnCentury ClubStuart FeldmanRichard MarcklingerLoyalty ClubGlenn RichardsGary ZimmermanClass <strong>of</strong> 1970Willis G. Gregory SocietyWilliam JuskoMortar <strong>and</strong> Pestle ClubJames MilesCentury ClubPaul R. SchwartzmyerLoyalty ClubDaniel J. DeleckiJoseph FiglowWilliam GlaveMary GrilloDavid HaynesRalph StephaniClass <strong>of</strong> 1971Willis G. Gregory SocietyAnna MackHoward Weintraub1886 ClubMargaret RappMortar <strong>and</strong> Pestle ClubP<strong>at</strong>ricia KrobothLoyalty ClubMichael ConstantinoMichael DiPirroMaxwell GrzywnaBarbara PotenskiStanley SzeflerClass <strong>of</strong> 1972Willis G. Gregory SocietyJohn KapoorMortar <strong>and</strong> Pestle ClubRobert BegertCentury ClubMichele DanishElizabeth MurphyLoyalty ClubRichard KlenkRoger Meyers28


Class <strong>of</strong> 1973Mortar <strong>and</strong> Pestle ClubMarcia DunhamPaul LipinogaSusan MarranoCentury ClubJeffrey ChaseGerald Senese Sr.Loyalty ClubPhilip CarcioneJohn FrischholzFrank LabargeThomas NealonJerald PasserBeth Resman-Targ<strong>of</strong>fRobert WagnerClass <strong>of</strong> 1974Willis G. Gregory SocietyGeorge LasezkayMortar <strong>and</strong> Pestle ClubWendy PritchardCentury ClubVitauts AlksSusan BellTheresa ChiaravallotiGary SenfDonald WillwerthLoyalty ClubChi-Deu ChangRonald GasbarroMax HillringFaith KayeLouis NicosiaElaine PhelanRichard PosnerBruce RocheAlgis RudinskasClaudia TwistP<strong>at</strong>ty WilsonLinda ZientekClass <strong>of</strong> 1975Willis G. Gregory SocietyChung ChuJee-Young ChuCarol Gl<strong>of</strong>fWai-Yung Florence HoHenry HuDan WongKen Yee1886 ClubSue MarrSvein OieCentury ClubBarbara Jean EdwardsKaren HarmsMichael LevittJeanne LillLinda LombardiDanny Dahying ShenDavid SmithTarik VeysogluLoyalty ClubPaul BembenistaGerald BraunStephen TurkovichJoseph TwistClass <strong>of</strong> 1976Willis G. Gregory SocietyMichael JayMario Rocci Jr.1886 ClubDaniel HornMortar <strong>and</strong> Pestle ClubDavid M. PyszPauline SitCentury ClubK<strong>at</strong>hleen CuberaPaula FalveyKaren Vitacolonna FalkJames ZahraLoyalty ClubBeth Resman-Targ<strong>of</strong>fClass <strong>of</strong> 1977Willis G. Gregory SocietySusan JayLinyee ShumCentury ClubVincent AndolinaPaul CoreyMichael ShakarjianLoyalty ClubHelen AbasuteLewis BarbiJo Anne GiblinMary Ann HallenbeckAlex HarrisAnthony HempelDoreen HeppertRobert McLeanBarbara McNiffJacob John UtzigClass <strong>of</strong> 1978Willis G. Gregory SocietyKarl FiebelkornGeorge LasezkayMortar <strong>and</strong> Pestle ClubKenneth NantkaSusan RozekJohn StahlCentury ClubJohn BurgholzerRosemarie BurgholzerJohn LettieriBruce SakowitzLoyalty ClubColleen CliffordPeter GalKenneth GrantMarcia HarrisJune JohnsonPaul KorusBarbara McNiffMary NufrykKaren OlesClass <strong>of</strong> 1979Willis G. Gregory SocietyKarl DonnTina FiebelkornDaphen ShumMortar <strong>and</strong> Pestle ClubF. Christopher ZusiCentury ClubC<strong>at</strong>herine CmayloBeverly CombsBarbara KapsiakDave LutomskiTimothy O’NeillChristopher OravetzLoyalty ClubDavid CaputoJames CzajkowskiGary DanoMargaret JohnsonAnna MauriVirginia MolkentinRosemary SilvestriniRussell TurckClass <strong>of</strong> 1980Willis G. Gregory SocietyGene MorseMortar <strong>and</strong> Pestle ClubMichael DarbyCentury ClubThomas EnglePeter IlligCraig KirkwoodPaul KunkemoellerStanley PiskorowskiS<strong>and</strong>ra SchifanoThomas StreeterLoyalty ClubKristine BanisterP<strong>at</strong>ricia Christ<strong>of</strong>fDiana ClarkeKevin Connors Jr.Kimberly Cripps-SuttonJames FitzgeraldGe<strong>of</strong>frey E. HillSheryl LiedtkeK<strong>at</strong>hleen McMeekin EspinaTimothy ReedS<strong>and</strong>ra ZukoskiClass <strong>of</strong> 1981Willis G. Gregory SocietyMary Anne Dannenh<strong>of</strong>ferStephen GirouxMario Rocci Jr.Michael TaylorK<strong>at</strong>hleen Torn<strong>at</strong>oreMortar <strong>and</strong> Pestle ClubEugene Hughto Jr.Elizabeth LudwigWalter LudwigCentury ClubAndrew DiLucaJoseph Geraci Jr.Ellen RosenbergRonald SchifanoLoyalty ClubAdrienne BlockDonna CarrSteven ChaoMark CostanzaValerie HaarmeyerRita KellerGregory KrielBarry MartinKaren QuarantoMary Priscilla SedgwickClass <strong>of</strong> 1982Willis G. Gregory SocietyThomas MadejskiMargaret Hempling McGlynnCentury ClubGeraldine AndersonKarl MetzgerDiana RichardsonBrian WhiteLoyalty ClubAmy BradleyPaul CainCurtis CranmerMichelle EimerJan KublitzClass <strong>of</strong> 1983Willis G. Gregory SocietyJoseph BalwierczakJames ErmerGene MorseJohn RodgersMortar <strong>and</strong> Pestle ClubDiane BassanelloCentury ClubFrank HeinrichCraig KirkwoodHarvey LischNdubuisi Chris NwankwoLoyalty ClubShelley BarnesCecilia ChengMary Ann Chiffy-CarusoBarbara FingarAlex HarrisGlenn HirtzelLisa KletterMark SinnettJill Rennie Steinh<strong>of</strong>fSteev SuttonJames W<strong>at</strong>tengelClass <strong>of</strong> 1984Willis G. Gregory SocietyJames BaxterShang-Ying P. KingMarilyn MorrisRachel Spire SmithThomas SmithMortar <strong>and</strong> Pestle ClubEdward BednarczykElizabeth LudwigLoyalty ClubM<strong>at</strong>thew BuehlerLinda FerreiraFern<strong>and</strong>o FerreiraMary Lyn HerzogRosa HillKenneth JaroszMarian McLaughlinMichael RossiCentury ClubPaul BentleyNancy BompczykGregory ChaseJohn KrakeSusan SchwalenstockerRobin VancakLisa WebsterClass <strong>of</strong> 1985Willis G. Gregory SocietyJamie BaxterDean SalyerMortar <strong>and</strong> Pestle ClubMichael DolanNadia SefeinCentury ClubJoseph FayadChristopher MessineoAnne ZajicekLoyalty ClubJoseph Eppolito Jr.James FennerLynn K<strong>at</strong>zCarolyn PriviteraLeslie Sicurella29


DONOR HONOR ROLLClass <strong>of</strong> 1986Willis G. Gregory SocietyBrian LoucksMortar <strong>and</strong> Pestle ClubKaren WhalenHelen Wong-SunCentury ClubK<strong>at</strong>hleen GondekSusan E. HughesKelly MoonRichard MoonSarah RonchettiAnita SmithLauren StotzLynn UberWalter UberLoyalty ClubSharon BrewerC<strong>at</strong>herine BroganGregory ClarkKaren JohnsonSteven KasperTamara KozlowskiGregory NelsonJulie ParkerMichael SurinColleen SwavyKimberly ZammitClass <strong>of</strong> 1987Willis G. Gregory SocietyMary Anne Dannenh<strong>of</strong>ferCentury ClubDonald H<strong>and</strong>leyChristopher JadochPamela JadochBill McLivertyMelissa MiccicheJohn WiernikowskiLoyalty ClubDeborah CarusoLynn IrenzaDavid FeldmanS<strong>and</strong>ra HellwigJohn ManzoMark SinnettClass <strong>of</strong> 1988Willis G. Gregory SocietyLinyee ShumMortar <strong>and</strong> Pestle ClubAndrea HessCentury ClubWendy LongdenElaine SoldiLoyalty ClubTheodore BurrMichelle P<strong>at</strong>ricia CallahanLisa CragleAnn DuquinMurali GouruKim PalmquistEvelyn RedaVincent RedaCraig StraleyCarolyn TomaniClass <strong>of</strong> 1989Willis G. Gregory SocietyGayle BrazeauCentury ClubCyrus ArdalanThomas GossLoyalty ClubSally BlackledgeLouis FrescuraTammy HayesAnita LeungAlice NicholsClass <strong>of</strong> 1990Willis G. Gregory SocietyJames BaxterStacy JohnsonMortar <strong>and</strong> Pestle ClubAndrea HessCentury ClubHerman Honwai IpVicky Yen IpBarbara RaceJennifer ThomasR<strong>and</strong>al WoodMichelle Wyant-SeeligLoyalty ClubKaren Lee-MiuKaren Ann NicosiaRobert WojtonClass <strong>of</strong> 1991Mortar <strong>and</strong> Pestle ClubGayle KleinCentury ClubShaun Michael CobbJoann HilburgerJulie Ann HostetlerKaren MlodozeniecTeresa TantilloLoyalty ClubInger DarlingAngela FarrellLynn K<strong>at</strong>zSheila SchiavoneClass <strong>of</strong> 1992Willis G. Gregory SocietyStephen GrothMortar <strong>and</strong> Pestle ClubMolly LewisCentury ClubPaul BadoreMark JarosinskiAnnie RodriguezLisa SaubermannLoyalty ClubKaren ConnKristen Noel CzerowMichelle Holt-MaceyJohn MaceyJoelle PawlickiC<strong>at</strong>herine ReinardClass <strong>of</strong> 1993Mortar <strong>and</strong> Pestle ClubSteven HanselGerald WempleCentury ClubFong Tai CheungLoyalty ClubAlison Louise ConroyAnita DwaileebeAndrea Jane FoxSusan HoynowskiMarie Michele KellnerK<strong>at</strong>ie R<strong>and</strong>allClass <strong>of</strong> 19941886 ClubNicholas WolfgangMortar <strong>and</strong> Pestle ClubRebecca BubelCentury ClubStefan Br<strong>and</strong>Abdulla SalehSu Chean TingLoyalty ClubBrian BurnsRobert GoldenChristine TopolskiLora WalterTodd WalterClass <strong>of</strong> 1995Mortar <strong>and</strong> Pestle ClubJoseph SidotiCentury ClubJamie BelcastroNicole Fiorella KeenanLoyalty ClubStacey K<strong>at</strong>hleen FinazzoClass <strong>of</strong> 1996Mortar <strong>and</strong> Pestle ClubTy AndrewsStephan SeyboltLoyalty ClubDaniel BenfantiShreen BeshuresTimothy FahrenholzRuba JadallahMark LaQueSusan LaQueLisa Mour<strong>at</strong>Michele SpenceDoanh TranAngela Sui Yee WongClass <strong>of</strong> 1997Mortar <strong>and</strong> Pestle ClubLinda Moden AndrewsCentury ClubJohn DeAngelisRachel NeillLoyalty ClubDanielle BanaszakPeter GunthnerMindy MageeHaijing MeiClass <strong>of</strong> 1998Willis G. Gregory SocietyYu-Nien Tom SunElizabeth TheophilosLoyalty ClubLisa GohoLucy GradMichael KonciljaJeffrey OlekClass <strong>of</strong> 1999Mortar <strong>and</strong> Pestle ClubJudianne SlishCentury ClubCarrie KennettKaren SeilerLoyalty ClubBradley ChaseMaria DybalaMindy MageeHaijing MeiWeihua QiuChristine TopolskiLonny WinterClass <strong>of</strong> 2000Mortar <strong>and</strong> Pestle ClubJudianne SlishCentury ClubCarrie KennettKaren SeilerLoyalty ClubMaria DybalaLynne Marie KilnerKimberly ZammitClass <strong>of</strong> 2001Century ClubAnne HuselsteinKevin MillsKenneth SansoneLoyalty ClubCarrie McClinticClass <strong>of</strong> 2002Willis G. Gregory SocietyPeter Brody Jr.Century ClubJoanne GreeniaJeffrey ScottLoyalty ClubMelanie DeToneUrsula HahnWoo-In LeeK<strong>at</strong>e McElwainElizabeth MilesJoseph MilesCoreen MontagnaWilliam PrescottEric SaweyClass <strong>of</strong> 2003Mortar <strong>and</strong> Pestle ClubIonut TeacaCentury ClubChristopher SlombaLoyalty ClubAnnette BirdJulie DrakeK<strong>at</strong>y SalernoJennifer SummervilleVirginia TawaClass <strong>of</strong> 2004Century ClubHe<strong>at</strong>her Marie BissellRachel TodtenhagenLoyalty ClubElizabeth OrnellaDaniel WeeksClass <strong>of</strong> 2005Mortar <strong>and</strong> Pestle ClubLynn CarlsonSeana O’MaraCentury ClubDavid AdamsLori CornueLoyalty ClubAm<strong>and</strong>a AntonikSoSum ChackDoanh Tran30


CORPORATIONS, FOUNDATIONS AND FRIENDSClass <strong>of</strong> 2006Loyalty ClubAm<strong>and</strong>a Erl<strong>and</strong>sonAngela LitfinClass <strong>of</strong> 2007Mortar <strong>and</strong> Pestle ClubRichard LinCentury ClubLisa ChalouxKevin DigiacomoMichael JohnsonJared RelesTyler Smith-StrutzN<strong>at</strong>haniel TurckStephen WebsterLoyalty ClubP<strong>at</strong>rick Comerford Jr.K<strong>at</strong>hleen ConnollyAmit GargAlison HuffmanLauren MaroniClass <strong>of</strong> 2008Mortar <strong>and</strong> Pestle ClubKavitha BhasiKaela KeluskarCentury ClubRenney BrittoM<strong>at</strong>thew DuellDeborah LianaAm<strong>and</strong>a PoworoznekThomas WalshLoyalty ClubJoette BumbaloWon Jin ChoiDaniel CorcoranAlfonse MutoJennifer PolitoClass <strong>of</strong> <strong>2009</strong>Willis G. Gregory SocietyLiliana YohonnCentury ClubKristen PregizerAlyssa RelesMichael SchifanoShweta UrvaLoyalty ClubShuming ChenTyler DimennaWillis G. Gregory Society$1 Million <strong>and</strong> aboveJohn & Editha Kapoor CharitableFound<strong>at</strong>ion$250,000 - $999,999H<strong>of</strong>fmann-La Roche, Inc.Pfizer, Inc.Novartis Pharmaceuticals Corpor<strong>at</strong>ionFaye Panasci$100,000 - $249,999Amgen, Inc.N<strong>at</strong>ional Multiple Sclerosis Society$50,000 - $99,999Astellas Pharma Global DevelopmentAmerican Feder<strong>at</strong>ion For AgingResearchGPI, Inc.Health Research, Inc.Kinex Pharmaceuticals, LLCMerck & Co., Inc.$10,000 - $49,999CPL Associ<strong>at</strong>es, L.L.C.Daiichi Sankyo Pharma Development, Inc.Susan G. Komen Breast CancerFound<strong>at</strong>ionEli Lilly <strong>and</strong> Company Found<strong>at</strong>ionRTI Intern<strong>at</strong>ionalSchering-Plough Corpor<strong>at</strong>ionTDM Pharmaceutical Research, LLCWalgreens$5,000 - $24,999Alcon Labor<strong>at</strong>ories, Inc.Allergan Pharmaceuticals, Inc.CVS Caremark Charitable Trust, Inc.CVS <strong>Pharmacy</strong>GileadCarolyn GirouxJohnson & JohnsonSharon MillerBarbara ModenHenry A. Panasci Jr. Charitable TrustRite Aid Corpor<strong>at</strong>ion$1,000 - $4,999American Associ<strong>at</strong>ion <strong>of</strong> Colleges <strong>of</strong><strong>Pharmacy</strong>Wayne <strong>and</strong> Lorraine AndersonS<strong>at</strong>hy <strong>and</strong> V<strong>and</strong>ana Balu-IyerThomas <strong>and</strong> Maria BardosCharles BeeverAaiampour BehzadMarlene BickelDaniel BrazeauErin BrodyRuth BuckleyCommunity Health Found<strong>at</strong>ion <strong>of</strong>Western <strong>and</strong> Central New YorkCVS Corpor<strong>at</strong>ionRaymond Dannenh<strong>of</strong>ferJoAnn DonnChristine Gabos ErmerFamily Medicine <strong>Pharmacy</strong>, Inc.Fillmore <strong>and</strong> Fisher <strong>Pharmacy</strong>, Inc.Forster’s <strong>Pharmacy</strong> Inc.Ho Leung <strong>and</strong> Sun-Mi FungGlaxoSmithKlineGeorge <strong>and</strong> Barbara HoleMary HuJohnson & JohnsonMargaret JuskoShue KingKinney Drugs, Inc.Gerhard <strong>and</strong> Rosalyn LevyS<strong>and</strong>ra MadejskiMcKesson Corpor<strong>at</strong>ionMedical Park <strong>Pharmacy</strong>, Inc.Middleport Family Health CenterWilliam MorrisRozanne MykaDavid <strong>and</strong> Jan PanasciNACDS Found<strong>at</strong>ionNiagara HospiceNYS Council <strong>of</strong> Health-SystemPharmacistsOmnicareDonna RocciRochester Drug Cooper<strong>at</strong>ive, Inc.J. Rutowski PharmaciesSears HoldingsShireDavid <strong>and</strong> Samantha StagneyRobert <strong>and</strong> Ninfa StraubingerTarget StoresMary TaylorWal-Mart Stores, Inc.Anita WeintraubWilliam Wallace <strong>and</strong> Leigh Y<strong>at</strong>es1886 Club2121 Main Street <strong>Pharmacy</strong>, Inc.Akron <strong>Pharmacy</strong>/Town Country GiftsCuba <strong>Pharmacy</strong>Independent Health Associ<strong>at</strong>ion, Inc.Cindy KonovitzAnthony <strong>and</strong> Camille PassarellaPharmacists’ Associ<strong>at</strong>ion <strong>of</strong> WesternNew York<strong>Pharmacy</strong> First<strong>Pharmacy</strong> Society Of RochesterPine <strong>Pharmacy</strong>UB <strong>School</strong> <strong>of</strong> <strong>Pharmacy</strong> StudentAssoci<strong>at</strong>ionMortar <strong>and</strong> Pestle ClubAmerican Express Found<strong>at</strong>ionThe Ellicottville <strong>Pharmacy</strong>GlaxoSmithKline Found<strong>at</strong>ionHoll<strong>and</strong> <strong>Pharmacy</strong>, Inc.The Medicine ShoppeJames OdomPfizer Found<strong>at</strong>ionCentury ClubAkzo Nobel Inc.Rebecca BrierleyBristol-Myers Squibb Found<strong>at</strong>ion, Inc.Paul <strong>and</strong> Julie BukowskiMicheal <strong>and</strong> K<strong>at</strong>hleen CuberaLois D’AmbrosioJ. Rutowski, Inc.Gregory <strong>and</strong> Rosalie MadejskiMary MadejskiClara OgundeleThomas <strong>and</strong> Joan PetersMargaret Walsh SchultzDavid SodaStephen <strong>and</strong> Linda YoungLoyalty ClubAlan Adams <strong>and</strong> K<strong>at</strong>hryn LyonsDave DiehlDavid <strong>and</strong> Julie DonohueGE Found<strong>at</strong>ionDennis <strong>and</strong> Diane FischerDavid <strong>and</strong> Joan HectorWojciech KrzyzanskiHong LiHarry <strong>and</strong> Anne McConnellThe Merck Company Found<strong>at</strong>ionNicholas PasqualinoGary <strong>and</strong> Bernice ReynoldsSiemens Medical Solutions USA, IncAndrew <strong>and</strong> Bonnie TangalosLoius <strong>and</strong> Amy YannelloMarc <strong>and</strong> P<strong>at</strong>ricia ZieglerClass <strong>of</strong> <strong>2010</strong>Century ClubNicholas FalcoLoyalty ClubJennifer BiernackiSusan ChangNicholas FuscoKey:Willis G. Gregory Society: $1,000 <strong>and</strong> above1886 Club: $500 - $999Mortar <strong>and</strong> Pestle Club: $250 - $499Century Club: $100 - $249Loyalty Club: $99 & belowThis report includes donors who made gifts <strong>and</strong> planned gift commitmentsbetween July 1, <strong>2009</strong> <strong>and</strong> June 30, <strong>2010</strong>. Every effort has been made toensure the accuracy <strong>of</strong> the inform<strong>at</strong>ion. In the event <strong>of</strong> an error or omission,please contact the SoPPS Development Office <strong>at</strong> (716) 645-3432 so th<strong>at</strong> wemay upd<strong>at</strong>e our records.31


THE HAYES SOCIETYThe Hayes Society honors individuals who have made legacy gifts to the <strong>School</strong> <strong>of</strong> <strong>Pharmacy</strong> <strong>and</strong> Pharmaceutical Sciencesthrough a bequest or other method <strong>of</strong> deferred giving.Thomas BardosAllen BarnettThomas Blanchard ‘61Daniel & Gayle BrazeauRobert ‘53 & Nina Doran ‘53Pamela Maude Emerson ‘52Joseph Figlow ‘70Edward & Jean Frank ‘54Carol Gl<strong>of</strong>f ‘75Joel Goodrich ‘59Jan ‘59 & Rose Mary Madejski ‘59DeWitt Niles ‘62Robert Ravin ‘57Irving Sultz ‘55To learn more or to notify the school <strong>of</strong> a legacy gift th<strong>at</strong> you have planned, please call the development <strong>of</strong>fice <strong>at</strong> (716) 645-3432 orvisit our web site <strong>at</strong> pharmacy.buffalo.edu.ENDOWED STUDENT SCHOLARSHIP AND FELLOWSHIP SUPPORTAversano-Strozzi Scholarship FundLisa LederhouseBrian WetzelJeannie Bauda DeMuth ScholarshipAmy TeleszRobert M. Cooper Memorial AwardPhilip BaskoKristen Della PennaCrimaldi-Madejski Scholarship FundJill JessmerCVS Scholarship FundMegan ConnaughtonDaniel GravesSusan LeeBasant RiwesScott WilsonX. Dave D’Ambrosio Scholarship FundDana NerenbergLyle A. Graves ScholarshipRachel DeppasThomas GuzzinoChristina HallJamie KaminskiBrian KerstenTracey NagelAllison PitmanGabrielle RiordenJohn Kapoor Fellowship inPharmaceutical SciencesSuraj BhansaliGilbert J. Kulick ScholarshipGrace ShyhLorren Larwood Scholarship FundNicole CieriMarie San RomanJulie VeneklaseFrancis & Edward Mayer ScholarshipThao DoanCindy VuongN<strong>at</strong>ional Associ<strong>at</strong>ion <strong>of</strong> Chain DrugStores Found<strong>at</strong>ion ScholarshipDanielle BaldwinAmy ColbyJenna HendershotDana NerenbergEdward Eli Neeman ScholarshipDavid KelseyCecil & Violet Newton Scholarship FundUzoamaka AtuegwuAmy BrightbillCaitlin CarpenterKelly ChanAlex<strong>and</strong>er ChuNghi DinhKaitlin GanleyChristina HewCurtis JohnstonYusouf KhanErin KnightShirley LauMelissa MackeyChristina ManciocchiPeggy MannKristina MarcheseNicholas MayerCalvin MeaneyMegan NelsonStephanie NewmanEvelyn NkeyasenK<strong>at</strong>herine OlsonTeresa Rizzone EbelAnthony RussoGrace ShyhLaura VespiSierra WolfordChung WongSylvia WongJessica WuHenry A. Panasci Scholarship FundNicholas FalcoMichael GrotaDavid JacobsAndrew StiversCopel & Max RubensteinScholarship FundMonika BaltaziukWomen’s Club Columbia CollegeScholarship FundMelissa ApaAlex<strong>and</strong>er CamposJosephine CheukChristopher DiehlMeagan ReebUB <strong>School</strong> <strong>of</strong> <strong>Pharmacy</strong> <strong>and</strong>Pharmaceutical Sciences GolfScholarshipNicholas FuscoCarolyn HempleMir<strong>and</strong>a MinhasGauri RaoUB <strong>School</strong> <strong>of</strong> <strong>Pharmacy</strong> <strong>and</strong>Pharmaceutical Sciences ScholarshipMonika BaltaziukHsin-Wei FuDaniel GravesGeorge NimakoKevin P<strong>at</strong>elAmy TelezWalgreens ScholarshipSeon Jo ParkWalmart ScholarshipAshley Smith32


“OUR DONORS have given us the futureby investing in Kapoor Hall.”The Pharmaceutical Care Learning CenterThe school is entering an exciting phase <strong>of</strong> our history, with classes set to begin in 2012 in Kapoor Hall.The first facility designed specifically for the needs <strong>and</strong> growth <strong>of</strong> the school, Kapoor Hall—with its fullyequipped classrooms <strong>and</strong> labor<strong>at</strong>ories—<strong>of</strong>fers students <strong>and</strong> faculty members many new opportunitiesfor research <strong>and</strong> academic success.“The move to Kapoor Hall is giving us an unbelievableopportunity to improve our curriculum,” said P<strong>at</strong>ty Havard,associ<strong>at</strong>e pr<strong>of</strong>essor <strong>of</strong> pharmacy practice. “Teaching studentsunder one ro<strong>of</strong>, using the newest technology <strong>and</strong> equipment,will allow us to introduce new teaching pedagogical methods<strong>and</strong> improve teaching efficiency. Efforts are under way toestablish interpr<strong>of</strong>essional collabor<strong>at</strong>ions with the other healthsciences schools to enhance multidisciplinary training for ourpharmacy students.”The centerpiece <strong>of</strong> Kapoor Hall is the two-story PharmaceuticalCare Learning Center (PCLC), which provides spaciousareas filled with the l<strong>at</strong>est technology <strong>and</strong> equipment th<strong>at</strong>further support the curriculum. Students will <strong>at</strong>tend lecturesin the pharmaceutical care classroom, <strong>and</strong> apply wh<strong>at</strong> theyhave learned in one <strong>of</strong> the 12 nearby p<strong>at</strong>ient assessment <strong>and</strong>counseling rooms, where they can practice basic clinical skills,including interviewing p<strong>at</strong>ients, taking blood pressures, immuniz<strong>at</strong>iontraining <strong>and</strong> certifying CPR. Faculty will be able toreview student progress <strong>and</strong> debrief students with the aid <strong>of</strong>video monitoring <strong>and</strong> capturing.The PCLC also includes a model pharmacy for students tolearn pharmacy best practices for managing medic<strong>at</strong>ion distribution<strong>and</strong> caring for outp<strong>at</strong>ients <strong>and</strong> inp<strong>at</strong>ients. A practicelabor<strong>at</strong>ory will provide an area <strong>and</strong> equipment for training inbasic <strong>and</strong> advanced compounding <strong>and</strong> inp<strong>at</strong>ient counseling.These will include simul<strong>at</strong>ion training in the center’s modelpharmacy, where students will learn pharmacy practice proceduresth<strong>at</strong> take place in hospital <strong>and</strong> community settings. Inthe p<strong>at</strong>ient assessment area, students will learn how to take ap<strong>at</strong>ient’s history, how to assess a p<strong>at</strong>ient’s condition throughvarious techniques, including diabetic foot examin<strong>at</strong>ions; <strong>and</strong>how to best educ<strong>at</strong>e p<strong>at</strong>ients on their health care <strong>and</strong> medic<strong>at</strong>ionmanagement.Prescott said th<strong>at</strong> these two learning spaces, coupled withthe newly developed Behling Simul<strong>at</strong>ion Center in the UBmedical school, “will <strong>of</strong>fer our students unique learningopportunities to help them grow as pr<strong>of</strong>essionals <strong>and</strong> leadersin p<strong>at</strong>ient care.”Reloc<strong>at</strong>ing to the South Campus will give UB <strong>Pharmacy</strong> closerproximity to the UB schools <strong>of</strong> medicine, dental medicine,public health <strong>and</strong> health pr<strong>of</strong>essions <strong>and</strong> nursing. The closeproximity to the Academic Health Center will promote the opportunity<strong>of</strong> interpr<strong>of</strong>essional collabor<strong>at</strong>ion on student training.Havard said the curriculum will include shared training(Continued on pg 34)William A. Prescott Jr., residency director <strong>and</strong> clinicalassistant pr<strong>of</strong>essor <strong>of</strong> pharmacy practice, is workingwith Havard on developing a new interpr<strong>of</strong>essionalcurriculum for the school th<strong>at</strong> focuses oncontinuity <strong>of</strong> care for p<strong>at</strong>ients. Prescottagreed th<strong>at</strong> the new building <strong>and</strong> thePCLC in particular will allow the facultyto use many new teaching methods.“I am most looking forward to the opportunitieswe will have to incorpor<strong>at</strong>e activelearning, including simul<strong>at</strong>ion-basedlearning,” he said.First floor, PharmaceuticalCare Learning Center33


The Pharmaceutical Care Learning Center (continued)opportunities, such as joining with the UB <strong>School</strong> <strong>of</strong> Nursing,to enhance “real-life” clinical practice-based environmentin the PCLC.Dean Wayne K. Anderson noted th<strong>at</strong> moving to KapoorHall will be a new beginning for the pharmacyschool, one th<strong>at</strong> was made possible throughthe generosity <strong>and</strong> vision <strong>of</strong> John Kapoor <strong>and</strong>the donors who followed his example <strong>and</strong>supported the new building.“Our donors have given us the future byinvesting in Kapoor Hall,” Anderson said.“Through their gifts, they have made it possiblefor us to include several important teaching <strong>and</strong>learning spaces where our students will receive thehighest quality educ<strong>at</strong>ion <strong>and</strong> training.”Second floor,PharmaceuticalCare Learning Center“THANKS TO THEIR GENEROSITY, we can look forward to the school’s future, one in which wecontinue to <strong>at</strong>tract the brightest students <strong>and</strong> faculty from around the world, make critical scientificdiscoveries <strong>and</strong> improve the quality <strong>of</strong> p<strong>at</strong>ient care: a future th<strong>at</strong> will happen in Kapoor Hall.”John <strong>and</strong> Editha Kapoor Hall34


Alumni Rel<strong>at</strong>ionsThe support <strong>of</strong> our alumni community has been invaluable in the various student events <strong>and</strong> outreachefforts th<strong>at</strong> have contributed to the continued success <strong>of</strong> our school.<strong>2009</strong>-10 Alumni Associ<strong>at</strong>ion ActivitiesThe <strong>2009</strong>-<strong>2010</strong> academic year was a busy one for the AlumniAssoci<strong>at</strong>ion. We were proud to recognize Donald Pritchard’53 as our <strong>2010</strong> Willis G. Gregory Award recipient <strong>and</strong> JosephRutowski ’84 as our <strong>2010</strong> Orville C. Baxter Award recipient.Donald <strong>and</strong> Joseph were recognized for their meritoriouscontributions to the field <strong>of</strong> pharmacy <strong>at</strong> the school’s <strong>2010</strong>Awards Ceremony.<strong>2009</strong> Reunion activities were held <strong>at</strong> the Gr<strong>and</strong> Isl<strong>and</strong> HolidayInn where the classes <strong>of</strong> 1954, 1959, 1984 <strong>and</strong> 1999 were recognized.Robert Miller ’59, Paul Scavone ’59 <strong>and</strong> Thomas Smith ’84gave heartwarming comments <strong>and</strong> reflections from their years<strong>at</strong> the school <strong>and</strong> how the educ<strong>at</strong>ion they <strong>and</strong> their classm<strong>at</strong>esreceived prepared them for their career p<strong>at</strong>hs. Those who<strong>at</strong>tended the <strong>2009</strong> Reunion received special opportunity toalso be involved with the groundbreaking activities for John& Editha Kapoor Hall which also took place during reunion.The American Society <strong>of</strong> Health-Systems Pharmacists mid-yearmeeting is the associ<strong>at</strong>ion’s premier n<strong>at</strong>ional outreach meeting.Our <strong>2009</strong> ASHP alumni reception was held in Las Vegas <strong>and</strong>over 120 alumni <strong>and</strong> guests <strong>at</strong>tended. We remind all ouralumni members who <strong>at</strong>tend the ASHP mid-year meetingto look for the associ<strong>at</strong>ion’s annual reception. It is a gre<strong>at</strong>way to reconnect with your alumni colleagues, faculty <strong>and</strong>students from the school!One <strong>of</strong> the primary missions <strong>of</strong> the associ<strong>at</strong>ion is support<strong>of</strong> students. In <strong>2010</strong>, the associ<strong>at</strong>ion organized a FarewellCelebr<strong>at</strong>ion reception for the PharmD Gradu<strong>at</strong>es <strong>of</strong> the Class<strong>of</strong> <strong>2010</strong> as well as for the <strong>2010</strong> BS <strong>and</strong> MS gradu<strong>at</strong>es fromthe Pharmaceutical Sciences. These celebr<strong>at</strong>ions were a gre<strong>at</strong>success! In <strong>2010</strong>, the associ<strong>at</strong>ion gave six $500 ‘grants-in-aid’awards to needy PharmD students as well as recognized SusanaYang ’10 <strong>and</strong> Brian Wetzel ’10 with awards <strong>at</strong> the <strong>2010</strong>Commencement in recognition <strong>of</strong> their valuable contributionsto the alumni associ<strong>at</strong>ion.The alumni associ<strong>at</strong>ion values the support it gives to theschool <strong>and</strong> students as well as the important role it plays inkeeping our alumni informed <strong>and</strong> connected to each other<strong>and</strong> activities here <strong>at</strong> the school.Joseph Rutowski ‘84<strong>and</strong> Donald Pritchard ‘53Class <strong>of</strong> 195935


Financial ReportsThe support to achieve our goals, the security to reach for the future, <strong>and</strong> the impetus for cre<strong>at</strong>ivity areallowed through our well-positioned financial portfolio.AMOUNT OF TOTAL SCHOOL REVENUEBY FUNDING SOURCESt<strong>at</strong>e9,163,186Grants <strong>and</strong> Contracts7,669,095Found<strong>at</strong>ions,Auxiliaries, <strong>and</strong> OtherTotal Revenue$20,695,3833,863,1020 1 2 3 4 5 6 7 8 9$2,181,323$95,194$525,223$5,418,660EXPENDITURES BY FUNDING SOURCEFOR RESEARCH AND TRAINING$313,250$174,064Federal NIHFederal OtherSt<strong>at</strong>eCorpor<strong>at</strong>e/IndustryFound<strong>at</strong>ions/Nonpr<strong>of</strong>itOtherENDOWMENT MARKET VALUE JUNE 20, <strong>2010</strong>($12.5M TOTAL MARKET VALUE)$6,632,829$238,597$2,327,137$95,733$297,597Scholarship Award MuseumSpecialDeanLectureDepartment$2,836,243$29,46836


<strong>School</strong>-Wide CommitteesN<strong>at</strong>ional Industrial Advisory CouncilOur school-wide committees give governance <strong>and</strong>oversight to our school. The structure, composition<strong>and</strong> charges <strong>of</strong> the school’s st<strong>and</strong>ing committeesare prescribed in the bylaws <strong>of</strong> the <strong>School</strong> <strong>of</strong><strong>Pharmacy</strong> <strong>and</strong> Pharmaceutical Sciences.Admissions CommitteeJennifer Hess (Chair) Javier Blanco, Fred Doloresco,Karl Fiebelkorn, Gayle Brazeau, Cindy Konovitz(ex <strong>of</strong>ficial), <strong>and</strong> William PrescottSupport: Cynthia Acara, Christine Stumm <strong>and</strong>Mark SauberanCurriculum CommitteeGayle Brazeau (Chair), Karl Fiebelkorn (ex <strong>of</strong>ficio),Cindy Konovitz (ex <strong>of</strong>ficio), Javier Blanco, PeterBrody, Deborah Chiarella, Wenging Gao, P<strong>at</strong>riciaGrace, Nicole Paolini Albanese, Erin Slazak,He<strong>at</strong>her Rodman (P1), Elyse Jackson (P2),Christina Hall (P3), Kirsten Butterfoss (P4)Executive CommitteeWayne Anderson (Chair), Edward Bednarczyk,K<strong>at</strong>hleen Boje, Gayle Brazeau, Rebecca Brierley,Peter Brody, Karl Fiebelkorn, Jennifer Hess,William Jusko, Cindy Konovitz, C<strong>and</strong>ise Morris,Gene Morse, Leigh Y<strong>at</strong>esSafety CommitteeAlfred Reiman (Chair), Vicki Rink, David Soda,Lee ZakStudent Academic Affairs CommitteeKarl Fiebelkorn (Chair), Joseph Balthasar,K<strong>at</strong>hleen Boje, Nicole Paolini, William PrescottTenure And PromotionWilliam Jusko (Co-Chair), Eugene Morse (Co-Chair), Marilyn Morris, Robert Straubinger,K<strong>at</strong>hleen Torn<strong>at</strong>oreWayne AndersonDean<strong>University</strong> <strong>at</strong> <strong>Buffalo</strong><strong>School</strong> <strong>of</strong> <strong>Pharmacy</strong> &Pharmaceutical SciencesMario Rocci, Jr., ‘76, ‘81Council ChairExecutive Vice PresidentPrevalere Life Sciences, Inc.Melton AffrimeSenior Vice PresidentGlobal Clinical PharmacologyICON Development SolutionsAllen Barnett ‘65Chief Executive OfficerKinex Pharmaceuticals, LLCLisa Benincosa ‘93Head, DMPKH<strong>of</strong>fmann-La Roche, Inc.James Daly ‘84, ‘85Senior Vice PresidentAmgen, Inc.Karl Donn ‘79Vice President,Drug DevelopmentParion SciencesJames Ermer ‘83Senior Director,Clinical PharmacologyShire PharmaceuticalsRonald Evens ‘69PresidentMAPS 4 Biotec, Inc.Pramod GuptaVice President,Quality & Chief Scientific OfficerColdstream Labor<strong>at</strong>oriesSteven Hansel ‘93Senior DirectorPfizer, Inc.Christoph HergersbergGlobal Technology Leader,BiosciencesGeneral ElectricGeorge Lasezkay ‘74, ‘78Retired, Corpor<strong>at</strong>e Vice President,Corpor<strong>at</strong>e DevelopmentAllergan, Inc.Margaret McGlynn ‘82, ‘83Retired President,Global Vaccines <strong>and</strong> Infectious DiseasesMerck & Co., Inc.Edward McNiff ‘75, ‘76, ‘83Senior Vice President,Pharmaceutical DevelopmentAgennix USA Inc.Richard Morrison ‘83Executive DirectorMerck & Co., Inc.David PanasciPresidentDHP Consulting, LLCJohn Rodgers ‘83Executive Vice President <strong>and</strong>Chief Oper<strong>at</strong>ing OfficerIndependent Health Associ<strong>at</strong>ion, Inc.Daniel Salazar ‘89Vice President,Transl<strong>at</strong>ional Medicine <strong>and</strong>Clinical PharmacologyDaiichi Sankyo PharmaMichael Taylor ‘81President <strong>and</strong> Chief Executive OfficerEnsemble Discovery Corpor<strong>at</strong>ionAvi Yacobi ‘75PresidentDOLE Pharma, LLC


Office <strong>of</strong> External Affairs<strong>University</strong> <strong>at</strong> <strong>Buffalo</strong>126 Cooke Hall<strong>Buffalo</strong>, NY 14260-1200NONPROFIT ORGU.S. POSTAGE PAIDBUFFALO NYPERMIT NO. 311Celebr<strong>at</strong>ion EventsActivity overviewWednesday, 9/14/11: Continuing Educ<strong>at</strong>ionEvening: Continuing Educ<strong>at</strong>ion Program on HypertensionThursday, 9/15/11, 12:30 – 1:50: Gerhard LevyDistinguished Lectureship in Pharmaceutical SciencesSpeaker: Leslie Benet, PhD, pr<strong>of</strong>essor <strong>of</strong> Bioengineering <strong>and</strong>Therapeutic Sciences, UCSF. Topic: The Clinical PharmaceuticalSciences. Wh<strong>at</strong> H<strong>at</strong>h Levy Wrought?Evening: Lecture ReceptionFriday, 9/16/11, 5:30 – 9:00: Open House <strong>and</strong>Tours <strong>of</strong> the <strong>School</strong>Key Note Speaker: Steven Sutton, PhD Class <strong>of</strong> 1983Reunion Activities for special recognition classes from1956, 1961, 1986 <strong>and</strong> 2001.S<strong>at</strong>urday, 9/17/11 Morning: South Campus Tours <strong>and</strong>John & Editha Kapoor HallPlease join us for a Continental Breakfast on South Campus,Tours <strong>of</strong> Kapoor Hall, a Walk ‘Down Memory Lane’ as wetour Cary & Foster Halls <strong>and</strong> see the future <strong>of</strong> health caretraining <strong>at</strong> the Behling Simul<strong>at</strong>ion Center as well as tourthe Health Sciences Library.S<strong>at</strong>urday, 9/17/11 Evening: Gala Dinner Dance <strong>at</strong>The <strong>Buffalo</strong> Club5:00 – 6:00 Priv<strong>at</strong>e Cocktail Party for ReunionRecognition Classes: Classes <strong>of</strong> 1956, 1961,1986 <strong>and</strong> 20016:00 – 7:30 Cocktail Party for all <strong>at</strong>tendees. Comments<strong>and</strong> present<strong>at</strong>ions from Key Note Speakers<strong>and</strong> Guests7:30 – 9:00 Dinner9:00 – 12:00 Dancing <strong>and</strong> Other ProgrammingSunday, 9/18/11Social Programs <strong>at</strong> various cultural <strong>and</strong> entertainmentvenues throughout the area.Please check http://www.pharmacy.buffalo.edu/for additional inform<strong>at</strong>ion.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!